Additional Information
Book Details
Abstract
Minimize the risks and maximize your surgical success with Current Surgical Therapy! Hundreds of preeminent general surgeons present you with today’s best treatment and management advice for a number of diseases and associated surgeries, discussing which approach to take, how to avoid or minimize complications, and what outcomes to expect. Current Surgical Therapy is indispensable for quick, efficient review prior to surgery, as well as when preparing for surgical boards and ABSITEs!
- Find the answers you need quickly inside the user-friendly book.
- Obtain dependable advice on patient selection, contraindications, techniques, pitfalls, and more from this best-selling surgical resource, trusted by generations of surgeons for decades as the definitive source on the most current surgical approaches.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front cover | cover | ||
Inside front cover | ifc1 | ||
Current Surgical Therapy, 11/e | i | ||
Copyright page | iv | ||
list of contributors | v | ||
preface | xxix | ||
Table of Contents | xxxi | ||
The Esophagus | 1 | ||
Esophageal Function Testing | 1 | ||
Disorders of Esophageal Function | 1 | ||
Gastroesophageal Reflux | 1 | ||
Achalasia | 1 | ||
Hypertensive Lower Esophageal Sphincter | 1 | ||
Diffuse Esophageal Spasm | 1 | ||
Hypercontractile “Nutcracker” Esophagus | 2 | ||
Ineffective Esophageal Motility | 2 | ||
Nonspecific Esophageal Motility | 2 | ||
Hiatal Hernia | 2 | ||
Diagnostic Tests for Esophageal Diseases | 2 | ||
Radiographic Imaging | 2 | ||
Endoscopy | 4 | ||
Esophageal Manometry | 5 | ||
Technical Considerations | 5 | ||
Diagnostic Tests for Gastroesophageal Reflux | 5 | ||
Esophageal Impedance | 6 | ||
Summary | 7 | ||
Acknowledgment | 7 | ||
Suggested Reading | 9 | ||
Gastroesophageal Reflux Disease | 9 | ||
Introduction | 9 | ||
Operative Indications | 9 | ||
Preoperative Evaluation | 9 | ||
Endoscopy | 9 | ||
Upper Gastrointestinal Series | 10 | ||
Esophageal Manometry | 10 | ||
Ambulatory pH Monitoring | 10 | ||
Surgical Treatment Options | 11 | ||
Minimally Invasive Surgical Technique | 11 | ||
Potential Operative Pitfalls | 12 | ||
Bleeding | 12 | ||
Short Esophagus | 12 | ||
Esophageal or Gastric Perforation | 12 | ||
Postoperative Care | 13 | ||
Common Postoperative Problems | 13 | ||
Dysphagia | 13 | ||
Gas Bloat Syndrome | 13 | ||
Reoperative Fundoplication | 13 | ||
Emerging Surgical Therapies for Gastroesophageal Reflux Disease | 13 | ||
Suggested Readings | 14 | ||
Endoluminal Approaches to Gastroesophageal Reflux Disease | 14 | ||
Introduction | 14 | ||
Preoperative Considerations | 14 | ||
Outcomes Assessment | 14 | ||
Stretta | 15 | ||
Background | 15 | ||
Technique | 15 | ||
Postoperative Care | 15 | ||
Outcomes | 15 | ||
EsophyX | 16 | ||
Background | 16 | ||
Technique | 16 | ||
Postoperative Care | 17 | ||
Outcomes | 17 | ||
Future Methods | 18 | ||
Summary | 18 | ||
Suggested Readings | 18 | ||
The Management of Barrett’s Esophagus | 19 | ||
Introduction | 19 | ||
Clinical Impact | 19 | ||
Clinical Features | 19 | ||
Treatment of Nondysplastic Barrett’s Esophagus | 19 | ||
Medical Management and Treatment | 19 | ||
Antireflux Surgery | 20 | ||
Endoscopic Therapies | 20 | ||
Treatment of Dysplastic Barrett’s Esophagus | 21 | ||
Endoscopic Ablative Treatments | 21 | ||
Endoscopic Mucosal Resection | 22 | ||
Esophagectomy | 23 | ||
Summary | 23 | ||
Selected Readings | 23 | ||
Endoscopic Treatment of Barrett’s Esophagus | 23 | ||
Introduction | 23 | ||
Histologic Features of Barrett’s Esophagus | 24 | ||
Surveillance Algorithm for Barrett’s Esophagus | 24 | ||
Endoscopic Ablation Therapies | 24 | ||
Thermal Ablation | 24 | ||
Photodynamic Therapy | 25 | ||
Cryospray Ablation | 25 | ||
Cryospray Ablation Technique | 25 | ||
Radiofrequency Ablation | 25 | ||
Radiofrequency Ablation Technique | 25 | ||
Endoscopic Mucosal Resection | 26 | ||
Endoscopic Mucosal Resection Technique | 26 | ||
Snare Technique | 26 | ||
“Suck and Cut” Technique | 26 | ||
Ligation Technique | 26 | ||
Cap Technique | 26 | ||
Endoscopic Submucosal Dissection | 26 | ||
Endoscopic Submucosal Resection Technique | 27 | ||
Summary | 27 | ||
Suggested Readings | 27 | ||
Paraesophageal Hernia | 27 | ||
Definition | 27 | ||
Clinical Manifestation | 29 | ||
Pathophisiology | 29 | ||
Diagnosis | 30 | ||
Therapy | 30 | ||
Indications for Surgery | 30 | ||
Surgical Anatomy | 31 | ||
Surgical Approach | 31 | ||
Excision of the Hernia Sac | 32 | ||
Assessment of Adequate Intraabdominal Esophageal Length and Management of a Short Esophagus | 32 | ||
Creating the Antireflux Barrier | 32 | ||
Repairing the Hiatus | 32 | ||
Gastropexy | 33 | ||
Insights and Controversies in Paraesophageal Hernia Surgery | 33 | ||
Surgical Management of Acute Paraesophageal Hernia | 33 | ||
Laparoscopic Versus Open | 33 | ||
A Novel Approach: Robotic-Assisted Surgery | 33 | ||
“To Mesh or Not to Mesh?” | 34 | ||
Collis Gastroplasty | 34 | ||
Antireflux Procedure | 35 | ||
Results | 35 | ||
Summary | 36 | ||
Suggested Readings | 36 | ||
The Management of Pharyngeal Esophageal (Zenker’s) Diverticula | 36 | ||
Introduction | 36 | ||
History | 36 | ||
Etiology | 36 | ||
Symptoms | 37 | ||
Diagnosis | 37 | ||
Indications for Surgery | 37 | ||
Operative Technique | 38 | ||
Postoperative Care | 38 | ||
Results | 38 | ||
Conclusion | 38 | ||
Suggested Readings | 38 | ||
The Management of Achalasia of the Esophagus | 39 | ||
Background | 39 | ||
Diagnosis | 39 | ||
Medical Therapy | 39 | ||
Pharmacologic | 39 | ||
Botulinum Toxin Injection | 39 | ||
Esophageal Pneumatic Dilation | 40 | ||
Per-Oral Endoscopic Myotomy | 41 | ||
Surgical Treatment | 41 | ||
Myotomy Technique and Outcomes | 41 | ||
Further Discussion | 42 | ||
Transthoracic Versus Transabdominal | 42 | ||
Open Versus Laparoscopic Versus Thoracoscopic | 42 | ||
Length of Myotomy | 42 | ||
Concomitant Antireflux Procedure: Nissen/Toupet/Dor | 42 | ||
Sigmoid Esophagus or Megaesophagus | 42 | ||
Surgical Myotomy Versus Endoscopic Treatment | 43 | ||
Summary | 43 | ||
ACKNOWLEDGMENT | 43 | ||
Suggested Readings | 43 | ||
Disorders of Esophageal Motility | 44 | ||
Introduction | 44 | ||
Classes of Esophageal Motility Disorders | 44 | ||
Spastic Dysmotility Disorders | 44 | ||
Diffuse Esophageal Spasm | 44 | ||
Hypercontracting Esophagus (Nutcracker Esophagus) | 44 | ||
Hypertensive Lower Esophageal Sphincter | 46 | ||
Ineffective Motility Disorder | 46 | ||
Secondary Esophageal Motility Disorders | 46 | ||
Suggested Readings | 47 | ||
The Management of Esophageal Carcinoma | 47 | ||
Assessment of the Extent of Disease and Selection of Treatment Options | 47 | ||
Treatment | 49 | ||
Neoadjuvant Chemotherapy and Chemoradiotherapy | 49 | ||
Surgical Resection | 50 | ||
High Probability of Localized Disease Confined to the Mucosa | 50 | ||
High Probability of Regional Disease | 50 | ||
High Probability of Systemic Disease | 50 | ||
Options for Esophageal Resection | 50 | ||
Perioperative Care: Morbidity and Mortality of Esophageal Resection | 52 | ||
Management of Complications | 53 | ||
Survival | 53 | ||
Functional Outcomes | 54 | ||
Conclusions | 54 | ||
Suggested Readings | 54 | ||
Neoadjuvant and Adjuvant Therapy of Esophageal Cancer | 54 | ||
Introduction | 54 | ||
Part I: Definition of Local-Regional Advanced Esophageal Cancer | 54 | ||
Clinical T1 Tumors | 54 | ||
Clinical T2 Tumors | 55 | ||
Clinical T3 Tumors | 55 | ||
Clinical N1-N2 Tumors | 55 | ||
Restaging After Preoperative Therapy | 55 | ||
Part II: Management of Local-Regional Advanced Esophageal Cancers | 55 | ||
Near Consensus | 55 | ||
Multimodality Therapy | 55 | ||
Type of Chemotherapy | 57 | ||
Controversial | 57 | ||
Definitive Chemoradiation | 57 | ||
Selective Definitive Chemoradiation | 57 | ||
Selective Chemoradiation Versus Chemotherapy in Adenocarcinoma | 57 | ||
Added Risks to Surgery of Chemoradiation | 57 | ||
Optimal Radiation Dose | 57 | ||
Different Approach to Siewert II and Siewert III Tumors | 58 | ||
PET-Directed Therapy | 58 | ||
Unknown | 58 | ||
Summary | 58 | ||
Suggested Readings | 58 | ||
Esophageal Stents | 58 | ||
Indications | 59 | ||
Historical Aspects | 59 | ||
Stent Design | 60 | ||
Clinical Evaluation and Technique | 60 | ||
Complications | 62 | ||
Special Considerations | 62 | ||
Conclusions | 62 | ||
Suggested Readings | 64 | ||
Esophageal Perforation | 64 | ||
Initial Therapy | 64 | ||
Management Decisions | 64 | ||
Cervical Perforation | 64 | ||
Thoracic Perforations | 64 | ||
Abdominal Perforations | 65 | ||
Special Situations | 67 | ||
Perforation Through a Malignancy | 67 | ||
Perforation With Achalasia | 67 | ||
Perforation of the Esophagus After Nissen Fundoplication | 67 | ||
Leakage of Esophagogastrostomy After Esophagectomy | 68 | ||
Suggested Readings | 68 | ||
The Stomach | 69 | ||
The Management of Benign Gastric Ulcer | 69 | ||
Introduction | 69 | ||
Etiology | 69 | ||
Presentation and Diagnosis | 69 | ||
Gastric Ulcer Types and Location | 69 | ||
Type I | 69 | ||
Types II and III | 70 | ||
Type IV | 70 | ||
Type V | 70 | ||
Stress-Related Mucosal Disease | 71 | ||
Cancer Risk After Resection | 71 | ||
Giant Ulcer | 71 | ||
Obstruction | 71 | ||
Perforation | 71 | ||
Surgical Technique | 71 | ||
Vagotomy and Drainage | 71 | ||
Extent of Resection | 73 | ||
Reconstruction Techniques | 73 | ||
Billroth I | 73 | ||
Billroth II | 74 | ||
Roux-en-Y | 75 | ||
Minimally Invasive Approach | 75 | ||
Suggested Readings | 76 | ||
The Management of Duodenal Ulcers | 76 | ||
Introduction | 76 | ||
Medical Management of Duodenal Ulcers | 77 | ||
Surgical Management of Duodenal Ulcers | 77 | ||
Perforated Duodenal Ulcers | 77 | ||
Bleeding Duodenal Ulcers | 78 | ||
Obstruction Duodenal Ulcers | 79 | ||
Intractable Duodenal Ulcers | 79 | ||
Atypical Indications | 80 | ||
Duodenal Closure | 80 | ||
Suggested Readings | 80 | ||
Zollinger-Ellison Syndrome | 80 | ||
Introduction | 80 | ||
Epidemiology | 80 | ||
Pathogenesis | 81 | ||
Clinical Presentation | 81 | ||
Diagnosis | 81 | ||
Clinical Evaluation | 81 | ||
Laboratory Testing | 81 | ||
Imaging Modalities | 81 | ||
Management | 82 | ||
Medical Management | 82 | ||
Surgical Management | 82 | ||
Sporadic Disease | 82 | ||
Multiple Endocrine Neoplasia Type 1 | 82 | ||
Metastatic Disease | 83 | ||
Reoperation | 83 | ||
Outcomes and Prognosis | 83 | ||
Postoperative Surveillance | 83 | ||
Areas of Controversies | 83 | ||
Conclusion | 84 | ||
Suggested Readings | 84 | ||
Mallory-Weiss Syndrome | 84 | ||
History | 84 | ||
Incidence, Pathophysiology, and Associated Conditions | 84 | ||
Diagnoses and Outcomes | 85 | ||
Treatment | 86 | ||
Surgery | 86 | ||
Summary | 86 | ||
Suggested Readings | 87 | ||
Gastric Adenocarcinoma | 87 | ||
Introduction | 87 | ||
Epidemiology and Presentation | 87 | ||
Pathology | 88 | ||
Preoperative Evaluation | 88 | ||
Staging | 88 | ||
Surgery | 88 | ||
Extent of Gastric Resection | 88 | ||
Gastric Reconstruction | 89 | ||
Nodal Station and Lymphadenectomy Definitions | 89 | ||
Location of Metastatic Lymph Nodes | 90 | ||
Potential Benefits of More Extensive Lymphadenectomy | 90 | ||
D2 Lymphadenectomy Technique for Subtotal/Distal Gastrectomy | 92 | ||
Greater Curvature (Station 4sb and 4d) Node Dissection | 92 | ||
Infrapyloric (Station 6) Node Dissection | 92 | ||
Hepatoduodenal Ligament Hepatic Artery (Station 12a) and Suprapyloric (Station 5) Node Dissection | 92 | ||
Common Hepatic Artery Dissection (Station 8a), Celiac Axis (Station 9), Proximal Splenic Artery (Station 11p), and Left Gastric Artery (Station 7) Lymph Node Dissection | 93 | ||
Lesser Curvature (Station 3) and Right Paracardial (Station 1) Node Dissection | 93 | ||
Specimen Processing for Pathology | 93 | ||
D2 Lymphadenectomy Technique for Total Gastrectomy | 94 | ||
Neoadjuvant and Adjuvant Therapy | 94 | ||
Follow-Up | 95 | ||
Summary | 95 | ||
Suggested Readings | 96 | ||
Gastrointestinal Stromal Tumors | 96 | ||
Introduction | 96 | ||
Pathologic Features | 96 | ||
Historical Background | 96 | ||
Receptor Tyrosine Kinase Mutations | 96 | ||
Epidemiology | 97 | ||
Age | 97 | ||
Hereditary Gastrointestinal Stromal Tumors | 97 | ||
Incidence | 97 | ||
Clinical Presentation | 97 | ||
Diagnosis | 97 | ||
Radiographic Studies | 97 | ||
Endoscopy, Fine-Needle Aspiration, and Biopsy | 98 | ||
Prognostic Factors | 98 | ||
Therapy for Primary Disease | 98 | ||
Surgery | 98 | ||
Technique | 98 | ||
Perioperative Therapy for Primary Disease | 100 | ||
Therapy for Advanced Disease | 100 | ||
Targeted Therapy | 100 | ||
Surgery | 102 | ||
Surveillance | 102 | ||
Conclusion | 102 | ||
Suggested Readings | 102 | ||
NCCN Guidelines | 102 | ||
Neoadjuvant Therapy | 102 | ||
Adjuvant Therapy | 102 | ||
Metastatic GIST: Imatinib Mesylate | 103 | ||
Metastatic GIST: Sunitinib Malate | 103 | ||
Metastatic Disease: Surgery | 103 | ||
Predicting Outcomes | 103 | ||
Background | 103 | ||
Morbid Obesity | 103 | ||
Overview | 103 | ||
Patient Selection | 103 | ||
Operative Procedures | 103 | ||
Laparoscopic Roux-en-Y Gastric Bypass | 104 | ||
Laparoscopic Adjustable Gastric Band | 105 | ||
Laparoscopic Vertical Sleeve Gastrectomy | 105 | ||
Laparoscopic Duodenal Switch With Biliopancreatic Diversion | 106 | ||
Outcomes and Complications | 106 | ||
Suggested Readings | 107 | ||
Small Bowel | 109 | ||
Small Bowel Obstruction | 109 | ||
Overview | 109 | ||
Evaluation and Diagnosis | 109 | ||
Nonoperative Management | 111 | ||
Operative Management | 112 | ||
Technical Considerations | 112 | ||
Adhesion Prevention | 112 | ||
Suggested Readings | 113 | ||
The Management of Crohn’s Disease of the Small Bowel | 113 | ||
Overview | 113 | ||
Medical Management | 113 | ||
Indications for Surgical Management | 115 | ||
Technical Considerations of Surgical Intervention | 116 | ||
Recurrence of Disease | 117 | ||
Selected Readings | 117 | ||
Strictureplasty in Crohn’s Disease | 118 | ||
Introduction | 118 | ||
Overview | 118 | ||
Indications and Contraindications | 118 | ||
Preoperative Preparation | 118 | ||
Intraoperative “Design of a Roadmap” | 118 | ||
Strictureplasty Techniques | 118 | ||
Short Strictureplasty | 118 | ||
Intermediate Length Procedures | 120 | ||
Long Enteroenterostomy | 120 | ||
Results | 120 | ||
Postoperative Short-Term Outcomes | 120 | ||
Long-Term Outcomes | 121 | ||
Summary | 121 | ||
ACKNOWLEDGMENT | 122 | ||
Suggested Readings | 122 | ||
The Management of Small Bowel Tumors | 122 | ||
Overview | 122 | ||
Carcinoid/Neuroendocrine Tumors | 122 | ||
Tumor Characteristics | 122 | ||
Clinical Presentation | 123 | ||
Diagnosis | 123 | ||
Treatment | 123 | ||
Adenocarcinoma | 123 | ||
Tumor Characteristics | 123 | ||
Clinical Presentation | 124 | ||
Diagnosis | 124 | ||
Treatment | 124 | ||
Gastrointestinal Stromal Tumors | 124 | ||
Tumor Characteristics | 124 | ||
Clinical Presentation | 125 | ||
Diagnosis | 125 | ||
Treatment | 125 | ||
Non-Hodgkin’s Lymphoma | 126 | ||
Tumor Characteristics | 126 | ||
Clinical Presentation | 126 | ||
Diagnosis | 126 | ||
Treatment | 126 | ||
Metastases | 127 | ||
Benign Tumors | 127 | ||
Adenomas | 127 | ||
Lipomas | 127 | ||
Hamartomas | 127 | ||
Hemangiomas | 127 | ||
Suggested Readings | 128 | ||
The Management of Diverticulosis of the Small Bowel | 128 | ||
Duodenal Diverticula | 128 | ||
Jejuno-Ileal Diverticular Disease | 130 | ||
Meckel’s Diverticulum | 131 | ||
Summary | 132 | ||
Suggested Readings | 132 | ||
Motility Disorders of the Stomach and Small Bowel | 132 | ||
Overview | 132 | ||
Motility Disorders of the Stomach | 132 | ||
Gastroparesis | 132 | ||
Evaluation of Gastroparesis | 133 | ||
Management of Gastroparesis | 134 | ||
Postgastrectomy Dumping | 135 | ||
Roux Stasis Syndrome | 136 | ||
Postvagotomy Diarrhea | 136 | ||
Motility Disorders of the Small Intestine | 136 | ||
Ileus of the Small Intestine | 136 | ||
Suggested Readings | 137 | ||
The Management of Short Bowel Syndrome | 137 | ||
Introduction | 137 | ||
Initial Management of the Abdominal Catastrophe That Leads to Short Bowel Syndrome | 138 | ||
Indications for Surgical Management of Short Bowel Syndrome | 138 | ||
Longitudinal Intestinal Lengthening and Tailoring | 139 | ||
Serial Transverse Enteroplasty Procedure | 140 | ||
Conclusion | 142 | ||
Suggested Readings | 142 | ||
The Management of Enterocutaneous Fistulas | 142 | ||
Overview | 142 | ||
Definition and Etiology | 142 | ||
Presentation | 142 | ||
Physiologic Effect and Complications | 143 | ||
Management | 143 | ||
Stabilization and Sepsis Control | 143 | ||
Resuscitation and Nutritional Support | 144 | ||
Wound Care | 144 | ||
Surgical Management | 144 | ||
Summary | 145 | ||
Suggested Readings | 145 | ||
Large Bowel | 147 | ||
Preoperative Bowel Preparation: | 147 | ||
Overview | 147 | ||
Historical Background | 147 | ||
Mechanism of Action of Oral Antimicrobial Agents | 147 | ||
Mechanical Bowel Preparation | 147 | ||
Is Mechanical Bowel Preparation Still Warranted? | 147 | ||
Summary | 148 | ||
Suggested Readings | 148 | ||
The Management of Diverticular Disease of the Colon | 149 | ||
Diverticulitis: Clinical Presentation | 149 | ||
Management | 149 | ||
Role of Elective Surgery in Acute Uncomplicated Diverticulitis | 149 | ||
Complicated Diverticulitis | 149 | ||
Role of Elective Surgery in Acute Complicated Diverticulitis (Pericolic Abscess, Hinchey I and II) | 149 | ||
Role of Elective Surgery in Acute Complicated Diverticulitis After Successful Treatment | 149 | ||
Role of Emergent Surgery in Acute Complicated Diverticulitis | 150 | ||
Free Perforation: Purulent and Fecal Peritonitis (Hinchey Stages III and IV) | 150 | ||
Critical Care Management and Resuscitation | 150 | ||
Surgical Management | 150 | ||
Abbreviated Laparotomy in Unstable Conditions | 150 | ||
Colostomy Versus Colocolostomy | 150 | ||
Laparoscopic Irrigation and Drainage for Hinchey II and III | 151 | ||
Summary and Conclusion | 151 | ||
Diverticular Bleeding | 151 | ||
Diagnosis and Management | 151 | ||
Suggested Readings | 153 | ||
The Management of Chronic Ulcerative Colitis | 154 | ||
Introduction | 154 | ||
Indications for Surgical Therapy | 154 | ||
Medically Refractory Disease | 154 | ||
Fulminant Colitis and Toxic Megacolon | 154 | ||
Bleeding | 154 | ||
Cancer | 154 | ||
Extracolonic Manifestations | 155 | ||
Growth Failure in Children | 155 | ||
Surgical Options | 155 | ||
Indications for a Subtotal Colectomy | 155 | ||
Surgical Procedures | 156 | ||
Total Colectomy | 156 | ||
Laparoscopic | 156 | ||
Open | 156 | ||
Proctectomy | 156 | ||
Laparoscopic Approach | 156 | ||
Open Proctectomy | 157 | ||
Perineal Approaches to Remove the Distal Rectum | 157 | ||
Intersphincteric Proctectomy | 157 | ||
Complications | 157 | ||
Proctocolectomy with Ileal Pouch–Anal Anastomosis | 157 | ||
J-Pouch Creation | 157 | ||
Ileal Pouch–Anal Anastomosis | 157 | ||
Double-Stapled Anastomosis | 157 | ||
Mucosectomy and Hand-Sewn Anastomosis | 158 | ||
Maneuvers to Ensure Reach of the J Pouch | 158 | ||
Other Types of Pouches | 159 | ||
Postoperative Course | 159 | ||
Complications | 159 | ||
Colectomy With Ileorectal Anastomosis | 159 | ||
Total Proctocolectomy With Continent Ileostomy (Kock’s Pouch) | 159 | ||
Conclusion | 160 | ||
Suggested Readings | 160 | ||
The Management of Toxic Megacolon | 160 | ||
Overview | 160 | ||
Incidence and Etiology | 160 | ||
Diagnosis | 160 | ||
Therapy | 161 | ||
Medical Therapy | 161 | ||
Management of Patients With Inflammatory Bowel Disease | 161 | ||
Management of Patients Without Inflammatory Bowel Disease | 162 | ||
Clostridium Difficile Colitis | 162 | ||
Surgical Therapy | 162 | ||
Outcomes | 162 | ||
Summary | 162 | ||
Suggested Readings | 162 | ||
Crohn’s Colitis | 163 | ||
Introduction | 163 | ||
Clinical Features | 163 | ||
Diagnosis | 163 | ||
Histology | 164 | ||
Serology | 164 | ||
Treatment | 164 | ||
Medical Management | 164 | ||
Surgical Management | 166 | ||
Stricture/Obstruction | 166 | ||
Perforation, Fistulae, and Abscess | 166 | ||
Massive Lower Gastrointestinal Bleeding | 166 | ||
Severe Colitis/Fulminant Colitis/Toxic Megacolon | 166 | ||
Extracolonic Manifestations of Crohn’s Disease | 167 | ||
Operations for Crohn’s Colitis | 167 | ||
Emergent Operation | 167 | ||
Segmental Colectomy | 167 | ||
Ileorectal Anastomosis | 167 | ||
Total Proctocolectomy with End Ileostomy | 168 | ||
Ileal Pouch Anal Anastomosis | 168 | ||
Proctectomy | 168 | ||
The Role of Laparoscopic and Robotic Surgery for Crohn’s Colitis | 168 | ||
Suggested Readings | 168 | ||
Ischemic Colitis | 169 | ||
Overview | 169 | ||
Anatomic Considerations | 169 | ||
Clinical Presentation | 169 | ||
Diagnosis | 169 | ||
Treatment | 171 | ||
Nonsurgical Management | 171 | ||
Surgical Management | 172 | ||
Summary | 172 | ||
Suggested Readings | 172 | ||
The Management of Clostridium Difficile Colitis | 173 | ||
Overview | 173 | ||
Clinical Manifestations | 173 | ||
Diagnosis of Clostridium Difficile Infection | 173 | ||
Medical Treatment | 174 | ||
Surgery | 175 | ||
Recurrent Infection | 176 | ||
Clostridium Difficile Infection and Inflammatory Bowel Disease | 176 | ||
Conclusion | 177 | ||
Suggested Readings | 177 | ||
Large Bowel Obstruction | 177 | ||
Overview | 177 | ||
Obstructions as a Result of Cancer | 177 | ||
Obstructions as a Result of Inflammation | 179 | ||
Obstructions as a Result of Colonic Volvulus | 179 | ||
Obstructions as a Result of Intussusception | 180 | ||
Obstructions as a Result of Hernia | 181 | ||
Obstructions as a Result of Ogilvie’s Syndrome (PseudoObstruction) | 181 | ||
Conclusion | 181 | ||
Suggested Readings | 181 | ||
Colonic Stenting | 181 | ||
Introduction | 181 | ||
Technique | 182 | ||
Patient Preparation | 182 | ||
Endoscopic Delivery | 183 | ||
Proximal Lesions and Stent Delivery | 183 | ||
Postplacement Care | 184 | ||
Complications | 184 | ||
Outcomes | 184 | ||
Summary | 184 | ||
Suggested Readings | 185 | ||
Acute Colonic Pseudo-Obstruction (Ogilvie’s Syndrome) | 185 | ||
Introduction | 185 | ||
Presentation and Diagnosis | 185 | ||
Management | 185 | ||
Neostigmine | 185 | ||
Colonoscopy | 186 | ||
Tube Cecostomy | 186 | ||
Surgery | 186 | ||
Summary | 187 | ||
Suggested Readings | 187 | ||
The Management of Colonic Volvulus | 187 | ||
Overview | 187 | ||
Sigmoid Volvulus | 187 | ||
Cecal Volvulus | 188 | ||
Transverse Colon Volvulus | 189 | ||
Splenic Flexure Volvulus | 190 | ||
Suggested Readings | 190 | ||
Rectal Prolapse | 190 | ||
Etiology and Presentation | 190 | ||
Evaluation | 190 | ||
Treatment | 191 | ||
Perineal Procedures | 191 | ||
Thiersch’s Procedure | 191 | ||
Mucosal Sleeve Resection (Delorme’s Procedure) | 191 | ||
Perineal Rectosigmoidectomy (Altemeier’s Procedure) | 192 | ||
Abdominal Procedures | 192 | ||
Ripstein’s Procedure | 192 | ||
Abdominal Rectopexy and Sigmoid Resection | 193 | ||
Abdominal Rectopexy | 193 | ||
Management of the Lateral Ligaments | 193 | ||
Laparoscopy | 193 | ||
Recurrent Prolapse | 194 | ||
Summary | 194 | ||
Suggested Readings | 194 | ||
The Management of Solitary Rectal Ulcer Syndrome | 194 | ||
Clinical Findings | 195 | ||
Diagnosis | 195 | ||
Histologic Findings | 195 | ||
Etiology | 195 | ||
Treatment | 195 | ||
Suggested Readings | 196 | ||
Surgical Management of Constipation | 196 | ||
Etiology and Workup | 196 | ||
Obstructed Defecation Syndrome | 197 | ||
Stapled Transanal Rectal Resection | 198 | ||
Slow-Transit Constipation | 199 | ||
Antegrade Colonic Enemas | 200 | ||
Sacral Nerve Stimulation | 200 | ||
Ostomy Creation | 200 | ||
Summary | 200 | ||
Suggested Readings | 200 | ||
Radiation Injury to the Small and Large Bowel | 200 | ||
Overview | 200 | ||
Radiation Dose Tolerance to the Small Intestine and Rectum | 201 | ||
Pathophysiology of Radiation to the Intestinal Tract | 201 | ||
Management of Radiation Enteritis | 201 | ||
Management of Radiation Proctitis | 203 | ||
Prevention of Radiation Enteritis and Proctitis | 204 | ||
Suggested Readings | 205 | ||
Hereditary Polyposis Syndromes | 205 | ||
Introduction | 205 | ||
Adenomatous Polyposis Syndromes | 205 | ||
Familial Adenomatous Polyposis | 205 | ||
Attenuated Familial Adenomatous Polyposis | 205 | ||
Mut Y Homolog–Associated Polyposis | 206 | ||
Turcot’s Syndrome | 207 | ||
Genetics | 207 | ||
Genotype-Phenotype Correlation in Familial Adenomatous Polyposis | 207 | ||
Surgical Therapy | 207 | ||
Timing of Surgery | 207 | ||
Choice of Operative Procedure | 207 | ||
Total Abdominal Colectomy and Ileorectal Anastomosis | 207 | ||
Restorative Proctocolectomy With Ileal Pouch–Anal Anastomosis, Stapled or With Mucosectomy | 208 | ||
Proctocolectomy With Permanent Terminal Ileostomy (or Kock’s Pouch) | 209 | ||
Medical Therapy | 209 | ||
Adenoma Chemoprevention | 209 | ||
Extracolonic Disease | 209 | ||
Upper Gastrointestinal Polyposis | 209 | ||
Desmoid Disease | 210 | ||
Clinical Scenarios | 210 | ||
Hamartomatous Polyposis Types | 210 | ||
Peutz-Jeghers Syndrome | 210 | ||
Juvenile Polyposis | 211 | ||
PTEN Tumor Hamartoma Syndromes | 212 | ||
Cowden’s Syndrome | 212 | ||
Bannayan-Riley-Ruvalcaba Syndrome | 212 | ||
Serrated Polyposis | 212 | ||
Conclusion | 212 | ||
Acknowledgment | 212 | ||
Suggested Readings | 212 | ||
Colon Cancer | 213 | ||
Background and Epidemiology | 213 | ||
Screening Recommendations | 213 | ||
Presentation, Diagnosis, and Workup | 213 | ||
Surgical Resection and Staging | 214 | ||
Open Versus Laparoscopic Colectomy | 214 | ||
Challenging and Complicated Cases | 215 | ||
Adjuvant Treatment | 217 | ||
Surveillance and Follow-Up | 217 | ||
Suggested Readings | 217 | ||
The Management of Rectal Cancer | 218 | ||
Introduction | 218 | ||
Diagnosis | 218 | ||
Treatment Approach by Stage | 218 | ||
Localized Disease | 218 | ||
Locally Advanced Disease | 221 | ||
Disseminated Disease | 222 | ||
Surgical Therapy | 222 | ||
Transanal Excision | 222 | ||
Total Mesorectal Excision | 222 | ||
Reconstruction | 223 | ||
Abdominoperineal Resection | 223 | ||
Perineal Dissection and Closure | 223 | ||
Laparoscopic and Robotic Proctectomy | 223 | ||
Selected Readings | 224 | ||
Tumors of the Anal Canal | 224 | ||
General Considerations | 224 | ||
Squamous Neoplasms | 224 | ||
Condyloma Acuminatum (Anal Wart) | 224 | ||
Anal Intraepithelial Neoplasia | 227 | ||
Bowen’s Disease | 228 | ||
Squamous Cell Carcinoma | 228 | ||
Adenocarcinoma | 230 | ||
Paget’s Disease | 230 | ||
Melanoma | 231 | ||
Neuroendocrine Tumors | 231 | ||
Mesenchymal Tumors | 231 | ||
Malignant Lymphoma | 231 | ||
Suggested Readings | 231 | ||
The Use of Positron Emission Tomographic Scanning in the Management of Colorectal Cancer | 232 | ||
Introduction | 232 | ||
Background | 232 | ||
Detection of Colorectal Cancer | 232 | ||
Screening for Colorectal Cancer | 233 | ||
Tumor Staging and Treatment Planning | 233 | ||
Assessment of Tumor Response | 234 | ||
Recurrent Colorectal Cancer | 235 | ||
Summary | 235 | ||
Suggested Readings | 235 | ||
The Use of Neoadjuvant and Adjuvant Treatment for Colorectal Cancer | 236 | ||
Overview | 236 | ||
Staging | 236 | ||
Adjuvant Therapy for Colon Cancer | 237 | ||
Stage III Colon Cancer | 237 | ||
Stage II Colon Cancer | 238 | ||
Neoadjuvant and Adjuvant Therapy for Rectal Cancer | 239 | ||
Surveillance | 240 | ||
Recommendations | 241 | ||
Rectal Cancer. | 241 | ||
Stage III Colon Cancer. | 241 | ||
Stage II Colon Cancer. | 241 | ||
Suggested Readings | 241 | ||
The Management of Colorectal Polyps | 241 | ||
Overview | 241 | ||
Histopathology and Natural History of Polyps | 242 | ||
Hyperplastic Polyps and Serrated Adenomas | 242 | ||
Hamartomas | 242 | ||
Adenomas | 242 | ||
Colonoscopic Polypectomy | 242 | ||
Approach to the Malignant Polyp | 243 | ||
Suggested Readings | 244 | ||
Management of Peritoneal Surface Malignancy | 245 | ||
Introduction | 245 | ||
Pseudomyxoma Peritonei and Peritoneal Metastases From Appendiceal Malignancy | 245 | ||
Management of Appendiceal Neoplasms With Peritoneal Dissemination | 245 | ||
Outcome With Histopathology as a Quantitative Prognostic Indicator | 245 | ||
Outcome With Peritoneal Cancer Index as a Quantitative Prognostic Indicator | 246 | ||
Outcome With Completeness of Cytoreduction as a Prognostic Indicator | 246 | ||
Peritoneal Metastases of Colorectal Origin | 246 | ||
Outcome of Peritoneal Metastases Treated With Modern Systemic Chemotherapy | 246 | ||
Complete Cytoreductive Surgery With Hyperthermic Perioperative Chemotherapy for Colorectal Cancer Peritoneal Metastases | 247 | ||
Outcome of Treatment for Peritoneal Metastases From Colorectal Cancer | 247 | ||
Improving Survival With Treatment of a Minimal Extent of Disease | 248 | ||
Diffuse Malignant Peritoneal Mesothelioma | 248 | ||
Treatment of Diffuse Malignant Peritoneal Mesothelioma | 249 | ||
Cytoreductive Surgery and Hyperthermic Perioperative Chemotherapy | 249 | ||
Results of Treatment of Diffuse Malignant Peritoneal Mesothelioma | 249 | ||
Treatment of Benign/Borderline Peritoneal Mesothelioma | 249 | ||
Peritoneal Metastases From Epithelial Ovarian Cancer | 249 | ||
Extent of Disease as a Prognostic Variable | 249 | ||
Role for Intraperitoneal Chemotherapy | 249 | ||
Peritoneal Metastases From Gastric Cancer | 250 | ||
An Evolution of Curative Treatment Strategies for Gastric Cancer With Peritoneal Metastases | 250 | ||
Importance of the Surgical Learning Curve | 251 | ||
Prevention of Gastric Carcinomatosis | 251 | ||
Suggested Readings | 251 | ||
The Management of Acute Appendicitis | 252 | ||
Overview | 252 | ||
Historical Perspective | 252 | ||
Anatomy and Pathophysiology | 252 | ||
Patient Presentation and Diagnosis | 252 | ||
History and Physical Examination | 252 | ||
Laboratory Examination | 252 | ||
Imaging | 252 | ||
Management of Acute Appendicitis | 253 | ||
Timing of Surgery | 253 | ||
Laparoscopic Versus Open Appendectomy | 253 | ||
Management of Nonperforated Appendicitis | 253 | ||
Laparoscopic Appendectomy | 253 | ||
Management of Perforated Appendicitis | 254 | ||
Antibiotics in Perforated Appendicitis | 254 | ||
Special Patient Situations | 255 | ||
Elderly | 255 | ||
Pregnancy | 255 | ||
Negative Appendectomy | 255 | ||
Suggested Readings | 255 | ||
Hemorrhoids | 255 | ||
Anatomy | 255 | ||
Etiology and Pathophysiology | 256 | ||
Incidence | 256 | ||
External Hemorrhoids | 256 | ||
Acute Thrombosis | 256 | ||
Quiescent External Hemorrhoids | 256 | ||
Internal Hemorrhoids | 257 | ||
Nonoperative Techniques | 257 | ||
Rubber Band Ligation | 257 | ||
Injection Sclerotherapy | 258 | ||
Infrared Coagulation | 258 | ||
Operative Techniques | 258 | ||
Open Hemorrhoidectomy | 258 | ||
Closed Hemorrhoidectomy | 258 | ||
Park’s Submucosal Excision | 259 | ||
Fixation Procedures | 259 | ||
Stapled Hemorrhoidopexy | 259 | ||
Suture Hemorrhoidopexy | 260 | ||
Partial Stapled Hemorrhoidopexy | 261 | ||
Doppler Guided Transanal Hemorrhoidal Ligation | 261 | ||
Special Situations | 261 | ||
Strangulated Hemorrhoids | 261 | ||
Hemorrhoids in Pregnancy | 261 | ||
Hemorrhoids in Inflammatory Bowel Disease | 261 | ||
Hemorrhoids in the Immunocompromised | 261 | ||
Hemorrhoid Varices and Portal Hypertension | 261 | ||
Suggested Readings | 261 | ||
Anal Fissure | 262 | ||
Treatment | 262 | ||
Acute Anal Fissure | 262 | ||
Medical Therapy for Chronic Anal Fissure | 262 | ||
Surgical Therapy for Chronic Anal Fissure | 263 | ||
Treatment Algorithm | 264 | ||
Acknowledgment | 265 | ||
Suggested Readings | 265 | ||
Anorectal Abscess and Fistula | 265 | ||
Introduction | 265 | ||
Abscess | 265 | ||
Diagnosis | 265 | ||
Treatment | 265 | ||
Fistulas | 266 | ||
Diagnosis | 267 | ||
Treatment | 268 | ||
Primary Fistulotomy | 268 | ||
Setons | 268 | ||
Advancement Flaps | 269 | ||
Fibrin Sealant | 270 | ||
Fistula Plug | 270 | ||
Ligation of Intersphincteric Fistula Tract | 271 | ||
Choice of Procedure | 271 | ||
Conclusion | 271 | ||
Suggested Readings | 274 | ||
Anorectal Stricture | 274 | ||
Definition | 274 | ||
Causes | 274 | ||
Clinical Presentation | 275 | ||
Diagnosis | 275 | ||
Nonoperative Management | 275 | ||
Medical Treatment | 275 | ||
Mechanical Dilation | 275 | ||
Operative Management | 275 | ||
Stricturotomy and Stricturectomy for Rectal Stricture | 275 | ||
Anoplasty for Anal Stricture | 275 | ||
Summary | 276 | ||
Suggested Readings | 276 | ||
The Management of Pruritus Ani | 277 | ||
Introduction | 277 | ||
Etiology | 277 | ||
Idiopathic Pruritus Ani | 277 | ||
Secondary Pruritus Ani | 277 | ||
Anorectal Conditions | 277 | ||
Infectious Conditions | 277 | ||
Dermatologic Conditions | 277 | ||
Systemic Conditions | 278 | ||
Patient Evaluation | 278 | ||
Treatment | 279 | ||
Idiopathic Pruritus Ani | 279 | ||
Secondary Pruritus Ani | 281 | ||
Summary | 281 | ||
Suggested Readings | 281 | ||
Surgical Treatment of Fecal Incontinence | 281 | ||
Overlapping SpHincteroplasty | 281 | ||
Sacral Nerve Stimulation | 282 | ||
Injectables | 282 | ||
Artificial Bowel Sphincter | 282 | ||
Other | 283 | ||
Suggested Readings | 283 | ||
The Management of Rectovaginal Fistula | 283 | ||
Introduction | 283 | ||
Causes | 283 | ||
Clinical Manifestation | 283 | ||
Classification of Rectovaginal Fistulae | 284 | ||
Preoperative Preparation | 284 | ||
Surgical Management | 284 | ||
Transanal Approach | 284 | ||
Fistulotomy | 284 | ||
Endorectal Advancement Flap | 284 | ||
Rectal Sleeve Advancement | 285 | ||
Kraske Approach | 285 | ||
Fibrin Glue | 285 | ||
Bioprosthetics | 285 | ||
Transvaginal Approach | 285 | ||
Vaginal Advancement Flap | 285 | ||
Transperineal Approach | 285 | ||
Episioproctotomy and Layered Closure | 285 | ||
Overlapping Sphincteroplasty | 285 | ||
Interposition Flaps | 286 | ||
Transabdominal Approach | 286 | ||
Omental Interposition | 286 | ||
Treatment Guidelines | 286 | ||
Fecal Diversion | 286 | ||
Choice of Repair | 286 | ||
Special Considerations | 287 | ||
Radiation-Induced Fistulae | 287 | ||
Crohn’s Disease | 288 | ||
Malignancy | 288 | ||
Acknowledgments | 288 | ||
Selected Readings | 288 | ||
The Management of Condyloma Acuminata | 288 | ||
Presentation and Evaluation | 289 | ||
Therapy | 289 | ||
Topical Therapies | 289 | ||
Podophyllin and Podophilox | 289 | ||
Trichloroacetic acid | 289 | ||
Cryotherapy | 289 | ||
5-Fluorouracil | 290 | ||
Miscellaneous Treatments | 290 | ||
Surgery | 290 | ||
Treatment Recommendations | 290 | ||
Human Papilloma Virus Vaccine | 291 | ||
Giant Condyloma Acuminata | 291 | ||
Suggested Readings | 293 | ||
The Management of Pilonidal Disease | 293 | ||
Pilonidal Disease: Common and Challenging | 293 | ||
Etiology and Characteristics | 293 | ||
The Name | 293 | ||
Causes | 293 | ||
Not a Congenital Condition | 293 | ||
Implications of Anatomy on Surgical Approach | 294 | ||
Making the Diagnosis | 294 | ||
A Changing Paradigm | 295 | ||
The Difficult Environment of the Cleft | 295 | ||
Diagnosis and Differential Diagnosis | 295 | ||
Imaging | 295 | ||
Acute Pilonidal Abscess Management | 295 | ||
Chronic Pilonidal Sinus | 296 | ||
Nonsurgical Approaches | 296 | ||
Surgical Approaches | 296 | ||
Unroofing | 296 | ||
Pit Picking | 296 | ||
The Goals of Surgery in Patients With Chronic Disease | 297 | ||
Asymmetric Flap Techniques | 297 | ||
The Karydakis Flap | 297 | ||
The Cleft Lift Procedure | 297 | ||
Differences Between the Cleft Lift Procedure and Other Flap Procedures | 299 | ||
The Limberg Flap | 300 | ||
Surgical Pitfalls | 300 | ||
Who Should Perform Surgical Procedures on Pilonidal Disease | 301 | ||
Cancer and Pilonidal Disease | 301 | ||
Summary | 301 | ||
Suggested Readings | 301 | ||
Lower Gastrointestinal Bleeding | 302 | ||
Definition | 302 | ||
Etiology | 302 | ||
Diverticulosis | 302 | ||
Neoplasia | 302 | ||
Colitis | 302 | ||
Arteriovenous Malformation | 302 | ||
Anorectal Disease | 303 | ||
Small Bowel Bleeding | 303 | ||
Iatrogenic Cause of Bleeding | 304 | ||
Diagnostic Assessment and Therapy | 304 | ||
Initial Evaluation and Resuscitation | 304 | ||
Colonoscopy | 304 | ||
Selective Mesenteric Angiography | 305 | ||
Technetium-Labelled Red Blood Scanning | 305 | ||
Other Options | 305 | ||
Surgery | 305 | ||
Summary | 306 | ||
Suggested Readings | 306 | ||
The Liver | 307 | ||
Cystic Disease of the Liver | 307 | ||
Overview and Clinical Presentation | 307 | ||
Diagnostic Evaluation | 307 | ||
Imaging Modalities | 307 | ||
Simple Cysts | 307 | ||
Polycystic Liver Disease | 308 | ||
Neoplastic Cysts | 309 | ||
Cystadenomas and Cystadenocarcinomas | 309 | ||
Intraductal Papillary Mucinous Neoplasm of the Bile Duct | 310 | ||
Traumatic Cysts | 310 | ||
Pyogenic Liver Abscess | 310 | ||
Suggested Reading | 310 | ||
The Management of Echinococcal Cyst Disease of the Liver | 311 | ||
Pathology and Classification | 311 | ||
Presentation and Diagnosis | 311 | ||
Laboratory Tests | 311 | ||
Imaging | 311 | ||
Treatment | 313 | ||
Nonoperative Therapy | 313 | ||
Benzimidazoles | 313 | ||
Percutaneous Therapy | 313 | ||
Operative Therapy | 314 | ||
Scolecoidal Agents | 314 | ||
Open Cyst Evacuation | 314 | ||
Laparoscopic Cyst Evacuation | 314 | ||
Pericystectomy | 315 | ||
Liver Resection/Transplantation | 315 | ||
Summary | 316 | ||
Uncomplicated Disease | 316 | ||
Complicated Disease | 317 | ||
Results | 317 | ||
Morbidity and Mortality | 317 | ||
Long Term | 317 | ||
Suggested Readings | 317 | ||
Cavernous Hepatic Hemangioma | 318 | ||
Pathophysiology and Clinical Presentation | 318 | ||
Diagnosis | 319 | ||
Management | 321 | ||
Surgical Resection | 321 | ||
Intraarterial and Ablative Therapies | 321 | ||
Infantile Hepatic Hemangioma | 321 | ||
Summary | 322 | ||
Suggested Readings | 322 | ||
The Management of Benign Liver Lesions | 322 | ||
Diagnosis and Imaging of Benign Liver Lesions | 322 | ||
Surgery for Benign Liver Lesions | 325 | ||
Liver Cysts | 325 | ||
Hepatic Hemangioma | 326 | ||
Focal Nodular Hyperplasia | 326 | ||
Hepatic Adenoma | 327 | ||
Summary | 327 | ||
Suggested Readings | 327 | ||
The Management of Malignant Liver Tumors | 328 | ||
Overview | 328 | ||
Hepatocellular Carcinoma | 328 | ||
Surgical Resection | 328 | ||
Liver Transplantation | 328 | ||
Thermal Ablation | 328 | ||
Embolization | 328 | ||
Fibrolamellar Hepatocellular Carcinoma | 328 | ||
Intrahepatic Cholangiocarcinoma | 329 | ||
Preoperative Assessment | 329 | ||
General Preoperative Assessment | 329 | ||
The Future Liver Remnant | 329 | ||
Operative Approach to Resection of Primary Liver Malignancies | 330 | ||
Incision and Access | 330 | ||
Right Hepatectomy | 330 | ||
Extended Right Hepatectomy | 331 | ||
Left Lobectomy | 331 | ||
Extended Left Hepatectomy | 331 | ||
Caudate Resection | 331 | ||
Segmental and Wedge Resections | 331 | ||
Suggested Readings | 332 | ||
Treatment for Hepatocellular Carcinoma: | 332 | ||
Introduction | 332 | ||
Evaluation | 333 | ||
Imaging | 333 | ||
Staging | 333 | ||
Treatment | 334 | ||
Liver Resection | 334 | ||
Liver Transplantation | 334 | ||
Suggested Readings | 335 | ||
Radiofrequency Ablation of Hepatic Metastases | 336 | ||
Overview | 336 | ||
Indications and Preoperative Assessment | 336 | ||
Technical Considerations | 336 | ||
Radiofrequency Ablation Devices | 336 | ||
Radiofrequency Ablation Approaches | 337 | ||
Open or Laparoscopic Radiofrequency Ablation | 337 | ||
Percutaneous Radiofrequency Ablation | 337 | ||
Complications | 338 | ||
Monitoring and Follow-Up | 338 | ||
Laboratory Follow-up | 338 | ||
Computed Tomographic Scan/Magnetic Resonance Imaging/Positron Emission Tomography | 338 | ||
Results and Response Rates | 339 | ||
Radiofrequency Ablation Versus Surgical Resection or Systemic Therapy | 339 | ||
Newer Technologies | 339 | ||
Microwave Ablation | 339 | ||
High-Intensity Focused Ultrasound Scan | 341 | ||
Computer-Assisted Soft-Tissue Surgery | 341 | ||
Conclusion | 341 | ||
Suggested Readings | 341 | ||
The Management of Hepatic Abscess | 341 | ||
Overview | 341 | ||
Pyogenic Hepatic Abscess | 342 | ||
Pathophysiology | 342 | ||
Diagnosis | 343 | ||
Treatment | 343 | ||
Antibiotics | 343 | ||
Drainage | 343 | ||
Amebic Hepatic Abscess | 344 | ||
Diagnosis | 344 | ||
Treatment | 345 | ||
Antibiotics | 345 | ||
Drainage | 345 | ||
Portal Hypertension | 353 | ||
Portal Hypertension: | 353 | ||
Management of Acute Variceal Hemorrhage | 353 | ||
Endoscopic Diagnosis and Therapy | 353 | ||
Luminal Tamponade | 354 | ||
Radiologic Interventions | 354 | ||
Transjugular Intrahepatic Portacaval Shunt | 354 | ||
Balloon-Occluded Retrograde Transvenous Obliteration | 355 | ||
Rebleeding Prophylaxis | 355 | ||
Surgical Shunts | 355 | ||
Total Portosystemic Shunts | 355 | ||
Partial Portosystemic Shunts | 356 | ||
Selective Shunts | 356 | ||
Comparison of Transjugular Intrahepatic Portacaval Shunt with Shunt Surgery | 356 | ||
Summary | 357 | ||
Suggested Readings | 357 | ||
The Role of Liver Transplantation in Portal Hypertension | 357 | ||
Etiologies of Portal Hypertension | 357 | ||
Pathophysiology of Portal Hypertension | 357 | ||
Medical Management of Portal Hypertension | 358 | ||
Surgical and Radiologic Management of Portal Hypertension | 358 | ||
Liver Transplantation | 358 | ||
Suggested Readings | 359 | ||
Endoscopic Therapy for Esophageal Variceal Hemorrhage | 359 | ||
Overview | 359 | ||
Endoscopic Therapy | 360 | ||
Endoscopic Band Ligation | 360 | ||
Endoscopic Sclerotherapy | 360 | ||
Other Endoscopic Methods | 360 | ||
Results | 360 | ||
Complications | 361 | ||
Prevention of First Variceal Hemorrhage | 361 | ||
Summary | 361 | ||
Suggested Readings | 361 | ||
Transjugular Intrahepatic Portosystemic Shunt | 361 | ||
Overview | 361 | ||
Indications | 361 | ||
Variceal Bleeding | 361 | ||
Ascites | 362 | ||
Hepatic Hydrothorax | 363 | ||
Hepatorenal Syndrome | 363 | ||
Hepatopulmonary Syndrome | 363 | ||
Budd-Chiari Syndrome | 363 | ||
Portal Gastropathy | 363 | ||
Technique | 363 | ||
Patient Preparation | 363 | ||
Access | 363 | ||
Diagnostic Assessment | 363 | ||
Shunt Placement | 364 | ||
Shunt Evaluation | 365 | ||
Special Cases | 365 | ||
Budd-Chiari Syndrome | 365 | ||
Parallel TIPS | 367 | ||
Transumbilical or Direct Portal Access | 367 | ||
TIPS Reversal/Revision | 367 | ||
Clinical Outcomes | 368 | ||
Clinical Response to TIPS | 368 | ||
Complications and Management | 368 | ||
Follow-up | 370 | ||
Summary | 370 | ||
Suggested Readings | 370 | ||
The Management of Refractory Ascites | 371 | ||
Introduction | 371 | ||
Pathophysiology | 371 | ||
Refractory Ascites | 371 | ||
Diagnosis of Ascites | 371 | ||
Paracentesis | 371 | ||
Treatments of Ascites | 371 | ||
Nonpharmacologic Therapies | 372 | ||
Dietary Sodium Restriction | 372 | ||
Fluid Restriction | 372 | ||
Pharmacologic Therapies | 372 | ||
Diuretics | 372 | ||
Albumin | 373 | ||
Vasoconstrictors | 373 | ||
Interventional Therapies | 373 | ||
Large Volume Paracentesis | 373 | ||
Transjugular Intrahepatic Portosystemic Shunts | 373 | ||
Peritoneovenous Shunts | 374 | ||
Spontaneous Bacterial Peritonitis | 375 | ||
Treatment of SBP | 375 | ||
SBP Prophylaxis | 375 | ||
Hepatic Hydrothorax | 375 | ||
Suggested Readings | 376 | ||
The Management of Hepatic Encephalopathy | 376 | ||
Overview | 376 | ||
Pathophysiology | 376 | ||
Classification and Managementof Hepatic Encephalopathy | 377 | ||
Overt Encephalopathy | 377 | ||
Oral Disaccharides | 377 | ||
Dietary Protein Restriction | 378 | ||
Low-Absorbable Antibiotics | 378 | ||
Other Therapies | 378 | ||
Hepatic Encephalopathy Associated With Acute Liver Failure | 378 | ||
Minimal Hepatic Encephalopathy | 378 | ||
Suggested Readings | 379 | ||
The Management of Budd-Chiari Syndrome | 379 | ||
Overview | 379 | ||
Presentation and Diagnosis | 379 | ||
Treatment | 380 | ||
Medical Therapy | 380 | ||
Interventional Radiology | 380 | ||
Surgical Therapy | 381 | ||
Portosystemic Shunting | 381 | ||
Liver Transplantation | 382 | ||
Summary | 382 | ||
Suggested Readings | 382 | ||
Gallbladder and Biliary Tree | 383 | ||
The Management of Asymptomatic (Silent) Gallstones | 383 | ||
Overview | 383 | ||
Epidemiology and Natural History | 383 | ||
Prophylactic Cholecystectomy | 384 | ||
Incidental Cholecystectomy | 384 | ||
Special Populations | 385 | ||
Diabetes | 385 | ||
Hemoglobinopathy | 385 | ||
Transplant | 386 | ||
Gallbladder Cancer | 386 | ||
Spinal Cord Injury | 386 | ||
Total Parenteral Nutrition | 386 | ||
Morbid Obesity | 386 | ||
Suggested Readings | 387 | ||
Acute Cholecystitis | 387 | ||
Overview | 387 | ||
Clinical Presentation and Evaluation | 388 | ||
Differential Diagnosis | 388 | ||
Management | 388 | ||
Laparoscopic Cholecystectomy | 388 | ||
Open Cholecystectomy | 389 | ||
New Developments | 390 | ||
Complications | 390 | ||
Suggested Readings | 390 | ||
The Management of Common Bile Duct Stones | 391 | ||
Overview | 391 | ||
Clinical Laboratory Findings | 391 | ||
Imaging Workup | 391 | ||
Transabdominal Ultrasonography | 391 | ||
Endoscopic Retrograde Cholangiopancreatography | 391 | ||
Magnetic Resonance Cholangiopancreatography | 392 | ||
Management | 392 | ||
Preoperative | 392 | ||
Intraoperative | 393 | ||
Technique of Laparoscopic Common Bile Duct Exploration | 394 | ||
Technique of Laparoscopic Direct Common Bile Duct Exploration | 394 | ||
Postoperative | 394 | ||
Summary | 395 | ||
Suggested Readings | 395 | ||
Acute Cholangitis | 395 | ||
Overview | 395 | ||
Epidemiology | 395 | ||
Pathogenesis | 395 | ||
Clinical Presentation | 396 | ||
Diagnosis | 396 | ||
Therapy | 397 | ||
Techniques of Biliary Drainage | 398 | ||
Endoscopic Drainage | 398 | ||
Percutaneous Transhepatic Drainage | 398 | ||
Surgical Drainage | 399 | ||
Principles of Management of Cholangitis Caused by Proximal Obstruction | 399 | ||
Suggested Readings | 399 | ||
Benign Biliary Strictures | 399 | ||
Iatrogenic Biliary Injuries | 399 | ||
Risk Factors for Biliary Injuries | 400 | ||
Patient-Related Factors | 400 | ||
Inflammation | 400 | ||
Acute Inflammation. | 400 | ||
Severe Chronic Inflammation. | 400 | ||
Congenital Abnormalities | 400 | ||
Aberrant Right Hepatic Ducts. | 400 | ||
Other Patient-Related Factors | 400 | ||
Large Impacted Gallstones. | 400 | ||
Obesity and Body Habitus. | 401 | ||
Procedure-Related Factors | 401 | ||
Misidentification: A Concept Problem | 401 | ||
Infundibular Technique. | 401 | ||
Intraoperative Cholangiography. | 401 | ||
Dissection of the Cystic Duct to the Confluence with the Common Hepatic Duct/Common Bile Duct. | 401 | ||
The Critical View of Safety Technique | 401 | ||
Top-Down Cholecystectomy. | 401 | ||
Technical Problems | 402 | ||
Failure to Obtain Secure Closure of the Cystic Duct. | 402 | ||
Thermal Injuries. | 402 | ||
Tenting Injuries. | 402 | ||
Surgeon-Related or Hospital-Related Factors | 402 | ||
Learning Curve Effect | 402 | ||
The Psychology of Human Error | 403 | ||
Equipment | 403 | ||
Vasculobiliary Injuries | 403 | ||
Extreme Vasculobiliary Injuries | 403 | ||
The Culture of Safety in Cholecystectomy | 403 | ||
Presentation and Investigation | 403 | ||
Pain and Sepsis | 403 | ||
Jaundice | 403 | ||
Bile Fistula | 404 | ||
Management of Biliary Injuries | 404 | ||
Management of Injuries Recognized at the Initial Operation | 404 | ||
Management of Biliary Injuries Diagnosed After Surgery | 404 | ||
Type A Injuries | 404 | ||
Type B Injuries | 404 | ||
Type C Injuries | 404 | ||
Type D Injuries | 404 | ||
Type E Injuries | 404 | ||
Timing of Surgery | 404 | ||
Preoperative Preparation | 404 | ||
Technical Aspects of Repair | 404 | ||
Exposure | 404 | ||
Identification and Repair | 405 | ||
Treatment of Vasculobiliary Injuries | 405 | ||
Outcome of Treatment | 406 | ||
Other Benign Biliary Strictures | 406 | ||
Biliary Strictures Secondary to Pancreatitis | 406 | ||
Stricture From Noniatrogenic Bile Duct Injuries | 406 | ||
Strictures From Calculous Disease | 406 | ||
Primary Sclerosing Cholangitis | 406 | ||
Benign Inflammatory Pseudotumors | 406 | ||
Suggested Readings | 407 | ||
Cystic Disorders of the Bile Ducts | 407 | ||
Overview | 407 | ||
Classification | 407 | ||
Etiology | 407 | ||
Epidemiology | 407 | ||
Diagnosis and Preoperative Evaluation | 407 | ||
Management | 408 | ||
Type I: Extrahepatic Bile Duct Cyst | 408 | ||
Type II: Extrahepatic Biliary Diverticulum | 408 | ||
Type III: Choledochocele | 409 | ||
Type IV: Multiple Bile Duct Cysts | 409 | ||
Type V: Caroli’s Disease | 409 | ||
Prognosis | 409 | ||
Suggested Readings | 409 | ||
Primary Sclerosing Cholangitis | 409 | ||
Demographics | 409 | ||
Etiology | 410 | ||
Associated Diseases and Complications | 410 | ||
Natural History and Prognostic Models | 410 | ||
Presentation | 410 | ||
Diagnosis | 411 | ||
Therapy | 411 | ||
Medical Therapy | 412 | ||
Nonoperative Interventional Therapy | 412 | ||
Operative Therapy | 412 | ||
Surgical Resection | 412 | ||
Liver Transplant | 412 | ||
Summary | 413 | ||
Suggested Readings | 413 | ||
86 Management of Cholangiocarcinoma | 414 | ||
Overview | 414 | ||
Clinical Presentation | 414 | ||
Intrahepatic Cholangiocarcinoma | 414 | ||
Perihilar and Distal Cholangiocarcinoma | 414 | ||
Diagnosis | 414 | ||
Perihilar and Cholangiocarcinoma | 414 | ||
Ultrasound Scan | 414 | ||
Contrast-Enhanced, Triple-Phase, Helical Computed Tomographic Scan | 415 | ||
Magnetic Resonance Cholangiopancreatography | 415 | ||
Endoscopic Ultrasound Scan | 415 | ||
Tumor Staging | 415 | ||
Preoperative Evaluation | 415 | ||
Surgical Treatment and Outcomes | 417 | ||
Perihilar Cholangiocarcinoma | 417 | ||
Distal Cholangiocarcinoma | 419 | ||
Palliation | 419 | ||
Summary | 419 | ||
Suggested Readings | 419 | ||
Gallbladder Cancer | 419 | ||
Overview | 419 | ||
Natural History, Biology, and the Role of Surgical Treatment | 420 | ||
Staging | 420 | ||
Clinical Scenarios | 420 | ||
Suspicion Prior to Surgery | 420 | ||
Discovery at the Time of Surgery or Final Pathology | 421 | ||
Radiologic Evaluation | 421 | ||
Management | 422 | ||
Polyps | 422 | ||
Suspicious Findings Prior to Surgery | 422 | ||
GBC Discovered at Time of Surgery | 423 | ||
GBC Incidentally Found on Final Pathology | 423 | ||
Definitive Surgical Therapy | 423 | ||
Stage-Based Therapy | 423 | ||
Adjuvant Therapy | 424 | ||
Palliative Care | 424 | ||
Suggested Readings | 424 | ||
Gallstone Ileus | 424 | ||
Pathogenesis | 424 | ||
Diagnosis | 424 | ||
Management | 425 | ||
Suggested Readings | 426 | ||
Obstructive Jaundice: | 427 | ||
Introduction | 427 | ||
Endoscopic Therapies for Obstructive Jaundice | 427 | ||
Endoscopic Retrograde Cholangiopancreatography | 427 | ||
Cholangioscopy | 427 | ||
Endoscopic Ultrasound | 427 | ||
Benign Biliary Obstruction | 427 | ||
Choledocholithiasis | 427 | ||
Postsurgical Complications | 428 | ||
Postsurgical Bile Leaks | 428 | ||
Postsurgical Strictures | 428 | ||
Primary Sclerosing Cholangitis | 429 | ||
Malignant Obstruction | 429 | ||
Suggested Readings | 429 | ||
The Pancreas | 431 | ||
Acute Pancreatitis | 431 | ||
Assessment of Severity | 431 | ||
Complications of Pancreatitis | 432 | ||
Management of Patients with Acute Pancreatitis | 432 | ||
Supportive Care | 432 | ||
Volume Resuscitation | 432 | ||
Metabolic Imbalance in Acute Pancreatitis | 432 | ||
Analgesia | 434 | ||
Nutrition | 435 | ||
Antibiotic Prophylaxis | 436 | ||
Endoscopic Retrograde Cholangiopancreatography | 436 | ||
Management of Complications of Acute Pancreatitis | 436 | ||
Pancreatic and Peripancreatic Fluid Collections | 436 | ||
Sterile and Infected Pancreatic Necrosis | 436 | ||
Percutaneous Drainage | 436 | ||
Endoscopic Necrosectomy | 437 | ||
Videoscopic-Assisted Retroperitoneal Débridement | 437 | ||
Laparoscopic Surgical Necrosectomy | 437 | ||
Open Surgical Management of Acute Pancreatitis | 438 | ||
Surgical Technique | 438 | ||
Closed Packing | 438 | ||
Open Packing, Planned Staged Relaparotomies With Repeated Lavage, and Continuous Lavage of Lesser Sac and Retroperitoneum | 439 | ||
Summary | 439 | ||
Demographics | 439 | ||
Severity Assessment | 439 | ||
Intensive Care Unit Admission | 439 | ||
Supportive Care | 439 | ||
Nutrition | 439 | ||
Minimally Invasive Step-Up Approach | 439 | ||
Suggested Readings | 439 | ||
The Management of Gallstone Pancreatitis | 440 | ||
Overview | 440 | ||
Presentation and Diagnosis | 440 | ||
Determination of Disease Severity | 440 | ||
Treatment | 441 | ||
Mild Disease | 441 | ||
Choledocholithiasis and Cholangitis | 442 | ||
Patients at High Risk | 442 | ||
Pregnant Patients | 443 | ||
Severe Disease | 443 | ||
Medical Management | 443 | ||
Intervention in Severe Pancreatitis | 443 | ||
Management of Pancreatic Necrosis | 443 | ||
Suggested Readings | 444 | ||
Pancreas Divisum and Other Variants of Dominant Dorsal Duct Anatomy | 444 | ||
Introduction | 444 | ||
Pancreatic Embryologic Development | 444 | ||
Clinical Significance | 445 | ||
Diagnostic Strategies | 445 | ||
Treatment | 447 | ||
Endoscopic Therapy | 447 | ||
Surgical Therapy | 447 | ||
Surgical Technique | 449 | ||
Conclusion | 449 | ||
Suggested Readings | 449 | ||
Pancreatic Necrosis | 450 | ||
Introduction | 450 | ||
Definitions and Diagnosis | 450 | ||
Role of Prophylactic Antibiotics | 450 | ||
Timing of Surgical Intervention | 450 | ||
Therapeutic Intervention for Pancreatic Necrosis | 450 | ||
Percutaneous Drainage | 452 | ||
Endoluminal Drainage | 452 | ||
Open Pancreatic Necronectomy | 452 | ||
Videoscopic Surgical Techniques | 453 | ||
Step-Up Approach | 453 | ||
Summary | 453 | ||
Suggested Readings | 454 | ||
The Management of Pancreatic Pseudocyst | 454 | ||
Overview | 454 | ||
Pathophysiology | 455 | ||
Presentation | 455 | ||
Diagnostic Evaluation | 455 | ||
Management | 456 | ||
Pseudocysts (After Acute Interstitial Edematous Pancreatitis) | 456 | ||
Walled-Off Pancreatic Necrosis (After Acute Necrotizing Pancreatitis) | 457 | ||
Disconnected Left Pancreatic Remnant | 457 | ||
Pseudocysts Associated With Chronic Pancreatitis | 457 | ||
Conclusion | 457 | ||
Suggested Readings | 458 | ||
Pancreatic Ductal Disruptions Leading to Pancreatic Fistula, Pancreatic Ascites, or Pancreatic Pleural Effusion | 458 | ||
Introduction | 458 | ||
Etiology and Complications | 458 | ||
Pancreaticocutaneous Fistulae | 459 | ||
Postoperative Fistulae | 459 | ||
The Spleen | 517 | ||
Hematologic Indications for Splenectomy | 517 | ||
Overview of Splenic Structure and Function | 517 | ||
Erythrocyte Disorders | 517 | ||
Membrane Defects | 517 | ||
Hemoglobinopathies | 517 | ||
Sickle Cell Anemia | 517 | ||
Thalassemia | 517 | ||
Autoimmune Hemolytic Anemias | 518 | ||
Enzyme Deficiencies | 518 | ||
Platelet Disorders | 518 | ||
Idiopathic Thrombocytopenic Purpura | 518 | ||
Thrombotic Thrombocytopenic Purpura | 518 | ||
Myeloproliferative Neoplasia | 518 | ||
White Blood Cell Disorders | 518 | ||
Preoperative Considerations | 519 | ||
Laparoscopic Splenectomy | 519 | ||
Postoperative Considerations | 519 | ||
Conclusion | 519 | ||
Suggested Readings | 520 | ||
Cysts, Tumors, and Abscesses of the Spleen | 520 | ||
Cysts | 520 | ||
Primary (True) Cysts | 520 | ||
Parasitic | 520 | ||
Nonparasitic | 520 | ||
Secondary (False) Cysts or Pseudocysts | 521 | ||
Treatment | 521 | ||
Splenectomy | 521 | ||
Partial Splenectomy | 521 | ||
Unroofing or Fenestration | 521 | ||
Tumors | 521 | ||
Malignant | 521 | ||
Lymphoproliferative Disease | 521 | ||
Myeloproliferative Disease | 522 | ||
Primary (Nonlymphoid) Neoplasms | 522 | ||
Metastatic Tumors | 522 | ||
Benign | 522 | ||
Treatment | 522 | ||
Abscesses | 522 | ||
Splenic Rupture | 523 | ||
Splenic Infarct | 523 | ||
Treatment | 523 | ||
Overwhelming Postsplenectomy Sepsis | 523 | ||
Suggested Readings | 524 | ||
Splenic Salvage Procedures: | 525 | ||
Nonoperative Management | 525 | ||
Guidelines for Nonoperative Management | 525 | ||
Approach to Nonoperative Management | 525 | ||
Role of Angioembolization | 525 | ||
Progression of Care | 526 | ||
Results of Nonoperative Management | 526 | ||
Operative Splenic Salvage | 526 | ||
Splenic Splenorrhaphy | 527 | ||
Partial Splenectomy | 528 | ||
Recommendations | 529 | ||
Suggested Readings | 529 | ||
Hernia | 531 | ||
Inguinal Hernia | 531 | ||
Overview | 531 | ||
Diagnosis | 531 | ||
Inguinal Hernia Repair | 531 | ||
Tissue Repair | 532 | ||
Mesh Repair | 532 | ||
Chronic Postinguinal Herniorrhaphy Pain | 535 | ||
Suggested Readings | 535 | ||
Recurrent Inguinal Hernia | 536 | ||
Introduction | 536 | ||
Prevention | 536 | ||
Anatomy | 536 | ||
Diagnosis | 536 | ||
Patient Preparation | 537 | ||
Anesthesia | 537 | ||
Repair Options | 537 | ||
Emergent | 537 | ||
Laparoscopic | 537 | ||
Stoppa Procedure | 537 | ||
Plug and Patch | 538 | ||
Complications | 539 | ||
Summary | 539 | ||
Suggested Readings | 539 | ||
Incisional, Epigastric, and Umbilical Hernias | 539 | ||
Incisional Hernias (Ventral Hernias) | 539 | ||
Umbilical Hernias | 539 | ||
Epigastric Hernia | 540 | ||
Approach to the Repair of Ventral Hernias | 540 | ||
To Repair or Not to Repair | 540 | ||
Techniques of Hernia Repair | 540 | ||
Tensioned Repair | 541 | ||
Tension-Free Repairs | 541 | ||
Mesh | 541 | ||
Combined Approach | 541 | ||
Laparoscopic Repair | 542 | ||
Open Repair/Abdominal Wall Reconstruction | 543 | ||
Follow-Up | 544 | ||
CONCLUSION | 545 | ||
Suggested Readings | 545 | ||
The Management of Semilunar Line, Lumbar, and Obturator Herniation | 545 | ||
Introduction | 545 | ||
Semilunar Line (Spigelian) Herniation | 545 | ||
Lumbar Herniation | 547 | ||
Obturator Herniation | 550 | ||
Summary | 552 | ||
Suggested Readings | 552 | ||
Athletic Pubalgia: | 553 | ||
Introduction | 553 | ||
Background | 553 | ||
Anatomy, Pathophysiology, and Differential Diagnosis | 553 | ||
Etiology | 553 | ||
People at Risk | 553 | ||
Presentation and Differential Diagnosis | 553 | ||
Diagnostic Approach | 554 | ||
Management | 554 | ||
Nonsurgical | 554 | ||
Surgical | 554 | ||
Laparoscopic Approach | 554 | ||
Open Mesh Approach | 556 | ||
Open Nonmesh Approaches | 556 | ||
Postoperative Course | 556 | ||
Clinical Quality Improvement | 556 | ||
Summary | 557 | ||
Suggested Readings | 557 | ||
Abdominal Wall Reconstruction | 557 | ||
Anatomy | 557 | ||
Skin and Adipose Tissue | 557 | ||
Fascia | 558 | ||
Muscles | 558 | ||
Peritoneum | 558 | ||
Patient Evaluation | 559 | ||
Approach to Repair | 559 | ||
Fascial Closure | 560 | ||
Fascial Defects | 560 | ||
Prosthetic Materials | 561 | ||
Synthetic Materials | 562 | ||
Absorbable Materials | 562 | ||
Bioprosthetics | 562 | ||
Conclusions | 563 | ||
Suggested Readings | 563 | ||
The Breast | 565 | ||
The Management of Benign Breast Disease | 565 | ||
Evaluation of Benign Breast Complaints | 565 | ||
Breast Masses | 565 | ||
Fibroadenomas | 566 | ||
Breast Cysts | 566 | ||
Breast Pain | 566 | ||
Nipple Discharge | 566 | ||
Breast Infection | 567 | ||
Abnormal Screening Mammograms | 567 | ||
Summary | 567 | ||
Suggested Readings | 567 | ||
Screening For Breast Cancer | 568 | ||
Overview | 568 | ||
Screening Recommendations | 568 | ||
Screening Modalities | 568 | ||
Breast Self Examination | 568 | ||
Clinical Breast Examination | 568 | ||
Screening Mammography | 568 | ||
Digital Mammography | 569 | ||
Biopsies | 569 | ||
High-Risk Screening | 570 | ||
Other Imaging Modalities | 570 | ||
Ultrasound Scan | 570 | ||
Magnetic Resonance Imaging | 570 | ||
Tomosynthesis | 571 | ||
Future | 571 | ||
Suggested Readings | 571 | ||
The Role of Stereotactic Breast Biopsy in the Management of Breast Disease | 571 | ||
Introduction | 571 | ||
History | 571 | ||
Certification | 572 | ||
Patient Selection, Indications, and Contraindications | 572 | ||
The Fundamentals | 573 | ||
The Procedure | 573 | ||
Challenging Clinical Scenarios | 576 | ||
Pathologic Correlation | 578 | ||
Conclusions and Future Directions | 578 | ||
Selected Readings | 579 | ||
Molecular Targets in Breast Cancer | 579 | ||
Molecular Profiling | 579 | ||
Luminal Subtypes | 580 | ||
HER2-Enriched | 580 | ||
Basal-Like | 580 | ||
Clinical Gene Expression Assays | 580 | ||
Estrogen Receptor Signaling Pathways | 580 | ||
Growth Factor Recptor Pathways and Down Stream Pathways | 582 | ||
PI3K/AKT Pathway | 583 | ||
Angiogenesis | 583 | ||
DNA Repair Pathways | 583 | ||
Poly(ADP-ribose) Polymerase Inhibitors | 583 | ||
Suggested Readings | 583 | ||
Breast Cancer: | 584 | ||
Introduction | 584 | ||
Diagnosis and Workup | 584 | ||
Treatment | 584 | ||
Noninvasive and Invasive Breast Cancer | 584 | ||
Breast Incision and Procedure Selection | 584 | ||
Localization | 584 | ||
Surgical Margins | 584 | ||
Staging the Axilla | 585 | ||
Sentinel Lymph Node Technique | 585 | ||
Axillary Lymph Node Dissection Technique | 586 | ||
Mastectomy Technique | 586 | ||
Reconstruction | 586 | ||
Nipple-Sparing or Total Skin-Sparing Mastectomy Technique | 586 | ||
Adjuvant Therapy | 587 | ||
Prophylactic Surgery | 587 | ||
Summary | 587 | ||
Suggested Readings | 587 | ||
Ablative Therapies in Benign and Malignant Breast Disease | 587 | ||
Overview | 587 | ||
Cryoablation | 588 | ||
Ongoing Cryoablation Trials | 588 | ||
Cryoablation Technique and Mechanism | 588 | ||
Cryoablation Benefits | 589 | ||
Radiofrequency Ablation | 590 | ||
Suggested Readings | 591 | ||
Lymphatic Mapping and Sentinel Lymphadenectomy | 592 | ||
Introduction | 592 | ||
Indications and Contraindications for Sentinel Lymph Node Biopsy | 592 | ||
Technical Aspects | 592 | ||
Special Considerations | 593 | ||
Neoadjuvant Chemotherapy | 593 | ||
Implications of Micrometastatic Disease and Isolated Tumor Cells Detected with Sentinel Lymph Node Biopsy | 594 | ||
Alternatives to Axillary Lymph Node Dissection for Positive Sentinel Lymph Nodes | 594 | ||
ACOSOG Z0011 Trial | 594 | ||
IBCSG-23-01 Trial | 594 | ||
AMAROS Trial | 594 | ||
Complications | 594 | ||
Future Directions | 594 | ||
Conclusion | 595 | ||
Suggested Readings | 595 | ||
The Management of The Axilla in Breast Cancer | 595 | ||
Overview | 595 | ||
Clinically Node-Negative Invasive Breast Cancer | 595 | ||
Management of Patients With Pathologically Negative Sentinel Nodes | 596 | ||
Management of Patients With Sentinel Node Micrometastases | 596 | ||
Management of Patients With Sentinel Node Macrometastases | 596 | ||
Clinically Node-Positive Invasive Breast Cancer | 596 | ||
Other Indications for Axillary Node Dissection | 596 | ||
Axillary Management for Ductal Carcinoma in Situ | 597 | ||
Axillary Management in Pregnant Patients | 597 | ||
Axillary Management in the Elderly | 597 | ||
Axillary Management in Male Breast Cancer | 597 | ||
Positive Axillary Nodes with an Occult Primary Tumor | 597 | ||
Axillary Management after Neoadjuvant Chemotherapy | 597 | ||
Management after Prior Axillary Surgery | 598 | ||
Management of Axillary Tumor Recurrence | 598 | ||
Axillary Radiation after Axillary Dissection | 598 | ||
Alternatives to Axillary Surgery | 598 | ||
Technical Aspects of Axillary Lymph Node Dissection | 599 | ||
Suggested Readings | 599 | ||
Inflammatory Breast Carcinoma | 599 | ||
Introduction | 599 | ||
Clinical Presentation | 599 | ||
Diagnosis and Staging | 600 | ||
Treatment | 600 | ||
Neoadjuvant Chemotherapy | 600 | ||
Surgery | 600 | ||
Radiation Therapy | 601 | ||
Targeted Therapy With Trastuzumab | 601 | ||
Hormonal Therapy | 601 | ||
Prognosis and Follow-Up | 601 | ||
Suggested Readings | 601 | ||
Ductal and Lobular Carcinoma in Situ of the Breast | 602 | ||
Ductal Carcinoma in Situ | 602 | ||
Diagnosis | 602 | ||
Treatment | 602 | ||
Surgical Therapy | 602 | ||
Radiation Therapy | 603 | ||
Hormonal Therapy | 604 | ||
Surveillance | 604 | ||
Lobular Carcinoma in situ | 604 | ||
Pathophysiology | 604 | ||
Natural History | 605 | ||
Diagnosis | 605 | ||
Treatment | 605 | ||
Specimen Evaluation | 605 | ||
Treatment Options | 606 | ||
Suggested Readings | 606 | ||
Advances in Neoadjuvant and Adjuvant Therapy for Breast Cancer | 607 | ||
Overview | 607 | ||
Neoadjuvant Systemic Therapy | 607 | ||
Neoadjuvant Chemotherapy | 607 | ||
Neoadjuvant Endocrine Therapy | 607 | ||
Surgery After Neoadjuvant Therapy | 607 | ||
Adjuvant Therapy | 608 | ||
Endocrine Therapy | 608 | ||
Premenopausal Patients | 609 | ||
Postmenopausal Patients | 609 | ||
Adjuvant Chemotherapy | 609 | ||
Molecular and Genomic Profiling | 609 | ||
Chemotherapy | 610 | ||
Her 2 neu–Targeted Therapy | 610 | ||
Summary | 611 | ||
Suggested Readings | 611 | ||
The Management of Recurrent and Disseminated Breast Cancer | 612 | ||
Introduction | 612 | ||
Relapse Patterns and Definitions | 612 | ||
Therapeutic Principles and Strategies | 612 | ||
Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy | 612 | ||
Preoperative Considerations | 612 | ||
Choice of Operation | 613 | ||
Technical Factors During Mastectomy for In-Breast Tumor Recurrence | 613 | ||
Complications and Their Prevention | 613 | ||
Recurrence After Mastectomy | 613 | ||
Preoperative Considerations | 613 | ||
Technical Tips | 614 | ||
Nodal Staging of Recurrent Breast Cancer after Breast Conservation or Mastectomy | 615 | ||
Lymph Node Recurrence | 616 | ||
Technical Tips | 616 | ||
Axillary Lymph Node Dissection | 616 | ||
Internal Mammary and Supraclavicular Lymph Node Metastasis | 617 | ||
Metastatic Breast Cancer | 617 | ||
Intact Primary Tumor in Patients with Metastatic Breast Cancer | 617 | ||
Isolated Distant Metastatic Disease | 617 | ||
Hepatic Breast Cancer Metastases | 617 | ||
Pulmonary Metastases | 618 | ||
Suggested Readings | 618 | ||
Male Breast Cancer | 618 | ||
Overview | 618 | ||
Risk Factors | 618 | ||
Presentation | 619 | ||
Diagnosis | 619 | ||
Treatment | 619 | ||
Prognosis | 620 | ||
Suggested Readings | 621 | ||
Breast Reconstruction Following Mastectomy: | 621 | ||
Indications | 621 | ||
Reconstructive Techniques | 622 | ||
Implants | 622 | ||
Two Stages | 622 | ||
One Stage | 622 | ||
Tissue Matrices | 622 | ||
Autologous Methods of Breast Reconstruction | 622 | ||
Fat Grafting | 623 | ||
Pedicled Flap Reconstruction | 623 | ||
The Latissimus Flap | 623 | ||
The TRAM Flap | 623 | ||
Free Flap Breast Reconstruction | 623 | ||
Suggested Readings | 624 | ||
Endocrine Glands | 625 | ||
Adrenal Incidentaloma | 625 | ||
Overview/Clinical Problem | 625 | ||
Imaging | 625 | ||
Density/Hounsfield Unit Assessment | 625 | ||
Size | 625 | ||
Rapid Office Biochemical Evaluation (Summary) | 627 | ||
Clinical EvAluation | 627 | ||
Cortisol Production (Zona Glomerulosa) | 627 | ||
History/Symptoms | 627 | ||
Physical Examination | 627 | ||
Biochemical Evaluation | 627 | ||
Aldosterone Producing Adenoma (Zona Fasciculata) | 628 | ||
Skin and Soft Tissue | 693 | ||
Nonmelanoma Skin Cancers | 693 | ||
Risk Factors and Precurser Lesions | 693 | ||
Clinical Evaluation of Basal Cell and Squamous Cell Cancers | 694 | ||
Clinical Appearance and Patient Examination | 696 | ||
Complete Excision and Peripheral Margin Evaluation | 697 | ||
Reconstruction of the Defect | 697 | ||
Confirmation of Negative Margins | 697 | ||
Enlarged Regional Nodes | 697 | ||
Radiation Therapy as Primary or Adjunctive Treatment | 697 | ||
Long-Term Follow-up of Basal and Squamous Cell Cancers | 697 | ||
Dermatfibrosarcoma Protuberans | 698 | ||
Treatment | 698 | ||
Cutaneous T-Cell Lymphoma | 698 | ||
Basal Cell Nevus Syndrome | 698 | ||
Bowen’s Disease | 698 | ||
Merkle Cell Carcinoma | 699 | ||
Angiosarcoma | 699 | ||
Adenexal Tumors of the Skin | 699 | ||
CONCULSION | 700 | ||
Acknowledgments | 700 | ||
Suggested Readings | 700 | ||
The Management of Cutaneous Melanoma | 700 | ||
Overview | 700 | ||
Biopsy Techniques | 700 | ||
Treatment of Primary Lesion | 700 | ||
Margins | 700 | ||
Incision and Reconstruction | 700 | ||
Special Sites | 701 | ||
Nail Bed | 701 | ||
Sole of Foot | 701 | ||
Ear | 702 | ||
Treatment of Regional Nodes | 702 | ||
Sentinel Node Biopsy | 702 | ||
Completion Lymphadenectomy | 703 | ||
Neck Dissection | 704 | ||
Axillary Dissection | 704 | ||
Inguinal Dissection | 704 | ||
Popliteal Dissection | 704 | ||
Ectopic Sentinel Nodes | 704 | ||
Adjuvant Radiotherapy and Adjuvant Interferon-alpha After Completion Dissection | 705 | ||
In-Transit Disease | 705 | ||
Local Therapies | 705 | ||
Regional Therapies | 705 | ||
Systemic Therapies | 705 | ||
Metastatic Disease | 705 | ||
Follow-Up | 705 | ||
Management of Recurrent Disease | 706 | ||
Conclusion | 706 | ||
Suggested Readings | 706 | ||
The Management of Soft Tissue Sarcoma | 706 | ||
Overview | 706 | ||
Etiology | 707 | ||
Grading | 707 | ||
Treatment | 707 | ||
Imaging | 707 | ||
Histology-Specific Treatment | 707 | ||
Atypical Lipomatous Tumor/ Well-Differentiated Liposarcoma | 707 | ||
Dermatofibrosarcoma Protuberans | 708 | ||
Malignant Fibrous Histiocytoma | 708 | ||
Myxofibrosarcoma | 708 | ||
Low Grade Fibromyxoid Sarcoma | 708 | ||
Angiosarcoma | 708 | ||
Radiation-Induced Sarcomas | 709 | ||
Malignant Peripheral Nerve Sheath Tumors | 709 | ||
Extremity Soft Tissue Sarcoma | 710 | ||
Clinical and Diagnostic Evaluation | 710 | ||
Surgical Treatment | 711 | ||
Adjuvant/Neoadjuvant Radiation Therapy and Chemotherapy | 713 | ||
Retroperitoneal Soft Tissue Sarcoma | 714 | ||
Clinical and Diagnostic Evaluation | 714 | ||
Anatomic Features of Retroperitoneal Sarcomas | 714 | ||
Technical Aspects of Retroperitoneal Sarcoma Resection | 715 | ||
Radiation Therapy | 715 | ||
Breast Sarcoma | 716 | ||
Primary Angiosarcoma | 716 | ||
Secondary Breast Angiosarcoma | 716 | ||
Phyllodes Tumor | 717 | ||
Desmoid Fibromatosis | 717 | ||
Metastatic Disease | 717 | ||
Summary | 717 | ||
Suggested Readings | 717 | ||
Evaluation of the Isolated Neck Mass | 718 | ||
Overview | 718 | ||
Differential Diagnosis | 718 | ||
Workup | 718 | ||
History | 718 | ||
Physical Examination | 718 | ||
Imaging | 720 | ||
Tissue Diagnosis | 720 | ||
Endoscopy and Biopsy | 722 | ||
Surgical Considerations | 723 | ||
Anesthesia and Airway Considerations | 723 | ||
Incisions | 723 | ||
Potential Nerve Injuries | 723 | ||
Other Potential Complications | 724 | ||
Suggested Readings | 724 | ||
Hand Infections | 724 | ||
Introduction | 724 | ||
Microbiology | 724 | ||
Methicillin-Resistant Staphylococcus Aureus | 724 | ||
The Diabetic and Immunocompromised Hand | 726 | ||
Bite Wounds | 726 | ||
Finger Infections | 726 | ||
Paronychia | 726 | ||
Diagnosis | 726 | ||
Treatment | 726 | ||
Felon | 727 | ||
Chest Wall, Mediastinum, Trachea | 751 | ||
The Management of Primary Chest Wall Tumors | 751 | ||
Overview | 751 | ||
Diagnosis | 751 | ||
Benign Bony and Cartilaginous Tumors | 751 | ||
Fibrous Dysplasia | 751 | ||
Osteochondroma | 751 | ||
Chondroma | 751 | ||
Malignant Bony and Cartilaginous Tumors | 752 | ||
Chondrosarcoma | 752 | ||
Osteosarcoma | 752 | ||
Ewing’s Sarcoma | 752 | ||
Solitary Plasmacytoma | 753 | ||
Benign Soft Tissue Tumors | 753 | ||
Lipomas | 753 | ||
Fibromas (Desmoid Tumors) and Fibromatosis | 753 | ||
Hemangiomas | 753 | ||
Benign Peripheral Nerve Sheath Tumors | 753 | ||
Malignant Soft Tissue Tumors | 753 | ||
Malignant Fibrous Histiocytoma | 753 | ||
Synovial Sarcomas | 753 | ||
Rhabdomyosarcomas | 753 | ||
Surgical Treatment of Chest Wall Tumors | 753 | ||
Chest Wall Resection | 753 | ||
Chest Wall Reconstruction | 754 | ||
Options for Chest Wall Reconstruction | 754 | ||
Summary | 755 | ||
Suggested Readings | 755 | ||
Mediastinal Masses | 755 | ||
Introduction | 755 | ||
Clinical Presentation and Diagnosis | 756 | ||
Signs and Symptoms | 756 | ||
Imaging | 756 | ||
Tumor Markers | 756 | ||
Biopsy Techniques | 756 | ||
Diagnosis | 756 | ||
Anterior Mediastinum | 757 | ||
Thymic Tumors | 757 | ||
Germ Cell Tumors | 757 | ||
Mature Teratomas | 758 | ||
Seminomas | 758 | ||
Nonseminomatous Germ Cell Tumors | 758 | ||
Lymphoma | 758 | ||
Thyroid and Parathyroid | 759 | ||
Middle Mediastinum | 759 | ||
Castleman’s Disease | 759 | ||
Mediastinal Lymphadenopathy | 759 | ||
Mediastinal Cysts | 760 | ||
Posterior Mediastinum | 760 | ||
Conclusion | 760 | ||
Selected Readings | 760 | ||
Primary Tumors of the Thymus | 761 | ||
Anatomy | 761 | ||
Pathology | 761 | ||
Evaluation | 761 | ||
Staging | 762 | ||
Principles of Therapy | 762 | ||
Operative Management | 762 | ||
Transsternal Thymectomy | 763 | ||
Video-Assisted Thoracic Surgery: Thymectomy | 763 | ||
Robotic Thymectomy | 763 | ||
Summary | 764 | ||
Suggested Readings | 764 | ||
The Management of Tracheal Stenosis | 764 | ||
Timing of Therapy | 764 | ||
Indications for Resection | 765 | ||
Factors to Consider for Tracheal Resection | 765 | ||
Airway Management | 765 | ||
Tracheal Resection and Reconstruction | 765 | ||
Results | 767 | ||
Suggested Readings | 767 | ||
The Management of Acquired Esophageal Respiratory Tract Fistula | 767 | ||
Overview | 767 | ||
Benign Esophageal Respiratory Fistulas | 767 | ||
Treatment of Benign Fistulas | 768 | ||
Repair of Benign Tracheoesophageal Fistula | 768 | ||
Repair of Benign Bronchoesophageal Fistulas | 769 | ||
Malignant Esophageal Respiratory Tract Fistula | 770 | ||
Esophageal Stents | 770 | ||
Airway Stents | 771 | ||
Summary | 771 | ||
Suggested Readings | 771 | ||
Repair of Pectus Excavatum | 772 | ||
Evaluation of the Patient with Pectus Excavatum | 772 | ||
Open Repair | 772 | ||
Minimally Invasive Pectus Excavatum Repair (Nuss Procedure) | 772 | ||
Complications of Minimally Invasive Repair | 773 | ||
Outcome of Pectus Excavatum Repair | 774 | ||
Suggested Readings | 775 | ||
Vascular Surgery | 777 | ||
Open Repair of Abdominal Aortic Aneurysms | 777 | ||
Overview | 777 | ||
Indications for Repair | 777 | ||
Preoperative Planning | 778 | ||
Surgical Repair | 778 | ||
Surgical Approaches | 778 | ||
Transperitoneal Approach | 779 | ||
Retroperitoneal Approach | 780 | ||
Operative Conduct | 781 | ||
Complications | 782 | ||
Conclusion | 783 | ||
Suggested Readings | 783 | ||
Endovascular Treatment of Abdominal Aortic Aneurysm | 783 | ||
Introduction | 783 | ||
Preoperative Considerations | 783 | ||
Aortic Neck Anatomy | 783 | ||
Iliofemoral Access | 783 | ||
Technical Details of the Procedure | 784 | ||
Postoperative Care and Follow-Up | 785 | ||
Complications | 785 | ||
Type I | 786 | ||
Type II | 786 | ||
Type III and Type IV | 786 | ||
Endotension | 786 | ||
Limb Thrombosis | 786 | ||
Migration | 786 | ||
Summary | 786 | ||
New Devices on the Horizon | 787 | ||
Suggested Readings | 787 | ||
The Management of Ruptured Abdominal Aortic Aneurysm | 788 | ||
Introduction | 788 | ||
Diagnosis and Evaluation | 788 | ||
Treatment | 788 | ||
Endovascular Repair | 788 | ||
Open Repair | 789 | ||
Discussion | 791 | ||
Summary | 791 | ||
Suggested Readings | 791 | ||
Abdominal Aortic Aneurysm and Unexpected Abdominal Pathology | 791 | ||
Overview | 791 | ||
Elective Abdominal Aortic Aneurysm Repair and Asymptomatic Abdominal Disease | 792 | ||
Cholelithiasis | 792 | ||
Appendix and Meckel’s Diverticulum | 792 | ||
Gastrointestinal Malignancies | 792 | ||
Genitourinary Malignancies | 793 | ||
Solid Organ Tumors | 793 | ||
Emergent Abdominal Aortic Aneurysm Repair and Concomitant Disease | 794 | ||
Emergent Laparotomy for Symptomatic Abdominal Pathology with Incidental Asymptomatic Abdominal Aortic Aneurysm | 794 | ||
Elective Laparotomy for Abdominal Pathology with Incidental Asymptomatic Abdominal Aortic Aneurysm | 794 | ||
Summary | 794 | ||
Suggested Readings | 795 | ||
The Management of Thoracic and Thoracoabdominal Aortic Aneurysms | 795 | ||
Introduction | 795 | ||
Indications for Surgery | 795 | ||
Preoperative Risk Assessment | 796 | ||
Open Surgical Management | 796 | ||
Adjuncts for Organ Protection | 797 | ||
Operative Technique | 797 | ||
Outcomes | 803 | ||
Endovascular Surgical Management | 804 | ||
Outcomes | 805 | ||
Alternative Approaches | 806 | ||
Suggested Readings | 807 | ||
The Management of Acute Aortic Dissections | 807 | ||
Overview | 807 | ||
Classification | 807 | ||
Presentation and Diagnosis | 808 | ||
Management | 808 | ||
Surgical Management of Stanford a Dissections | 808 | ||
Surgical Results with Acute Type a Dissections | 810 | ||
Management of Acute Type B Dissections | 810 | ||
Suggested Readings | 811 | ||
Carotid Endarterectomy | 811 | ||
Overview | 811 | ||
Clinical Presentation | 811 | ||
Clinical Status | 811 | ||
Imaging Studies | 811 | ||
Indications | 812 | ||
Carotid Endarterectomy Versus Carotid Stenting | 813 | ||
Carotid Endarterectomy: Operative Technique | 813 | ||
Preoperative Medical Regimen | 813 | ||
Anesthesia | 813 | ||
Patient Positioning | 813 | ||
Skin Incision | 814 | ||
Operative Technique | 814 | ||
Eversion Endarterectomy | 815 | ||
Completion Studies | 816 | ||
Unexpected Intraoperative Findings of the Internal Carotid Artery | 816 | ||
High Carotid Bifurcation | 816 | ||
Hypoplastic Internal Carotid Artery | 816 | ||
Thrombosed Internal Carotid Artery | 816 | ||
Complications | 816 | ||
Stroke | 816 | ||
Nerve Injury | 817 | ||
Myocardial Infarction | 817 | ||
Hyperperfusion Syndrome | 817 | ||
Recurrent Carotid Stenosis | 817 | ||
Combined Carotid Endarterectomy–Coronary Artery Bypass | 817 | ||
Suggested Readings | 817 | ||
The Management of Recurrent Carotid Artery Stenosis | 818 | ||
Incidence of Restenosis | 818 | ||
Timing of Restenosis and Pathogenesis | 818 | ||
Risk Reduction | 819 | ||
Diagnosis of Restenosis | 819 | ||
Indications for Reintervention | 820 | ||
Intervention for Recurrent Carotid Stenosis | 820 | ||
Reoperative Carotid Endarterectomy | 820 | ||
Technical Details | 820 | ||
Results | 821 | ||
Carotid Angioplasty and Stenting | 822 | ||
Technical Details | 822 | ||
Results | 822 | ||
Summary | 822 | ||
Suggested Readings | 822 | ||
Balloon Angioplasty and Stents in Carotid Artery Occlusive Disease | 823 | ||
Background | 823 | ||
Technical Considerations in Performance of Carotid Artery Stenting | 823 | ||
Design of Carotid Stent Systems | 825 | ||
Carotid Stents | 825 | ||
Embolic Protection Devices | 827 | ||
Periprocedural Management | 829 | ||
Antiplatelet Therapy | 829 | ||
Hemodynamic Instability | 829 | ||
Periprocedural Neurologic Assessment | 829 | ||
Follow-up | 830 | ||
Summary and Perspective | 830 | ||
Suggested Readings | 830 | ||
The Management of Aneurysms of the Extracranial Carotid and Vertebral Arteries | 830 | ||
Introduction | 830 | ||
Carotid Artery Aneurysms | 830 | ||
Etiology | 830 | ||
Presentation and Diagnosis | 831 | ||
Indications for Intervention | 831 | ||
Treatment | 831 | ||
Results | 835 | ||
Vertebral Artery Aneurysms | 835 | ||
Suggested Readings | 835 | ||
Brachiocephalic Reconstruction | 836 | ||
Introduction | 836 | ||
Clinical Presentation | 836 | ||
Diagnostic Evaluation | 836 | ||
Treatment | 837 | ||
Indication for Treatment | 837 | ||
Treatment Options | 838 | ||
Anatomic (Direct) Revascularization | 839 | ||
Endarterectomy | 839 | ||
Bypass Graft | 839 | ||
ExtraAnatomic (Indirect) Revascularization | 839 | ||
Arterial Transposition | 840 | ||
Endovascular Treatment | 841 | ||
Innominate Artery Interventions | 841 | ||
Left Common Carotid Artery | 841 | ||
Left Subclavian Artery | 842 | ||
Summary | 842 | ||
Selected Readings | 843 | ||
Upper Extremity Arterial Occlusive Disease | 843 | ||
Overview | 843 | ||
Etiology | 843 | ||
Systemic Disease | 843 | ||
Embolism | 844 | ||
Trauma | 844 | ||
Evaluation | 844 | ||
History and Physical Examination | 844 | ||
Noninvasive Vascular Evaluation | 845 | ||
Management | 846 | ||
Medical Therapy | 847 | ||
Endovascular Therapy | 847 | ||
Surgical Therapy | 847 | ||
Operative Exposure of the Subclavian Artery | 847 | ||
Surgical Reconstruction for Proximal Subclavian Artery Lesions | 848 | ||
Subclavian Artery Transposition | 848 | ||
Carotid-Subclavian Bypass | 848 | ||
Axillary Artery | 848 | ||
Brachial Artery | 849 | ||
Radial and Ulnar Arteries | 849 | ||
Angioaccess-Induced Arterial Steal Syndrome | 849 | ||
Summary | 850 | ||
Suggested Readings | 851 | ||
Aortoiliac Occlusive Disease | 851 | ||
Introduction | 851 | ||
Initial Evaluation and Indications for Intervention | 851 | ||
Direct Surgical Revascularization | 852 | ||
Aortobifemoral Bypass | 854 | ||
Iliofemoral Bypass | 856 | ||
ExtraAnatomic Bypass | 857 | ||
Femorofemoral Bypass | 857 | ||
Axillobifemoral Bypass | 857 | ||
Other Surgical Revascularization Options | 859 | ||
Complications of Surgical Revascularization | 859 | ||
Results of Surgical Revascularization | 860 | ||
Endovascular Interventions | 860 | ||
Complications of Endovascular Interventions | 861 | ||
Results of Endovascular Interventions | 861 | ||
Summary | 863 | ||
Suggested Readings | 863 | ||
Femoropopliteal Occlusive Disease | 863 | ||
Introduction | 863 | ||
Evaluation | 863 | ||
Treatment | 864 | ||
Medical | 864 | ||
Interventional | 864 | ||
Endovascular Treatment | 864 | ||
Surgical Treatment | 865 | ||
Discussion | 867 | ||
Summary | 868 | ||
Suggested Readings | 868 | ||
Tibioperoneal Arterial Occlusive Disease | 869 | ||
Patient Assessment | 869 | ||
Selection of Intervention | 870 | ||
Surgical Bypass | 870 | ||
Anesthesia and Positioning | 870 | ||
Operative Exposures | 871 | ||
Inflow Vessels | 871 | ||
Outflow Vessels | 871 | ||
Proximal Posterior Tibial and Peroneal Arteries | 871 | ||
Anterior Tibial Artery and Dorsalis Pedis Artery | 872 | ||
Conduit | 872 | ||
Inflow Anastomosis | 873 | ||
Tunnels for Bypass Grafts | 874 | ||
Outflow Anastomosis | 874 | ||
Endovascular Revascularization | 874 | ||
Indications for Intervention | 874 | ||
Vascular Access and Imaging | 874 | ||
Balloon Angioplasty and Stent Placement | 875 | ||
Other Technologies | 875 | ||
Postintervention Management and Surveillance | 875 | ||
Complications | 875 | ||
Future Treatment: Cell-Based Therapies | 875 | ||
Conclusion | 877 | ||
Suggested Readings | 877 | ||
Profunda Femoris Reconstruction | 877 | ||
Profunda Femoris Artery | 877 | ||
Basic Anatomy | 877 | ||
Operative Role | 877 | ||
Profunda Femoris as an Inflow Vessel | 877 | ||
Outflow | 878 | ||
Isolated Profundaplasty | 878 | ||
Operative Approaches | 878 | ||
Standard Anterior Approach | 878 | ||
Standard Anterior Approach for Extended Profundaplasty | 880 | ||
Anteromedial and Anterolateral Approach | 880 | ||
Posteromedial Approach | 881 | ||
Posterior Approach | 881 | ||
Endovascular Therapy | 881 | ||
Conclusion | 882 | ||
Suggested Readings | 882 | ||
Femoral and Popliteal Artery Aneurysms | 883 | ||
Overview | 883 | ||
Degenerative Femoral Aneurysms | 883 | ||
Introduction | 883 | ||
Clinical Presentation and Diagnosis | 883 | ||
Treatment | 883 | ||
Results | 884 | ||
Iatrogenic Femoral Pseudoaneurysms | 884 | ||
Introduction | 884 | ||
Clinical Presentation and Diagnosis | 885 | ||
Treatment | 885 | ||
Results | 886 | ||
Popliteal Aneurysms | 886 | ||
Introduction | 886 | ||
Clinical Presentation and Diagnosis | 886 | ||
Treatment | 887 | ||
Results | 887 | ||
Suggested Readings | 888 | ||
The Treatment of Claudication | 888 | ||
The Initial Evaluation of the Patient with Suspected Claudication | 888 | ||
Initial Management of the Patient with Claudication: Management of Limb Symptoms | 889 | ||
Initial Management of the Patient with Claudication: Management of Generalized Atherosclerosis | 889 | ||
Follow-Up after Initiation of Medical Management and Selection of Patients for Intervention | 890 | ||
Treatment of the Arterial Occlusive Lesions That Cause Claudication | 891 | ||
Summary | 892 | ||
Suggested Readings | 892 | ||
Pseudoaneurysms and Arteriovenous Fistulas | 893 | ||
PSEUdoaneurysms | 893 | ||
Definitions | 893 | ||
Risk Factors | 893 | ||
Diagnosis | 893 | ||
Treatment | 893 | ||
Observation | 893 | ||
Ultrasound Scan–Guided Compression | 893 | ||
Ultrasound Scan–Guided Thrombin Injection | 894 | ||
Endovascular Repair | 895 | ||
Open Surgical Repair | 895 | ||
Noninfected Pseudoaneurysms | 895 | ||
Infected Pseudoaneurysms | 896 | ||
Anastomotic Pseudoaneurysms | 896 | ||
Arteriovenous Fistula | 897 | ||
Diagnosis | 897 | ||
Treatment | 898 | ||
Open Surgical Repair | 898 | ||
Endovascular Repair | 898 | ||
Suggested Readings | 898 | ||
Axillofemoral Bypass | 898 | ||
Introduction | 898 | ||
Indications | 898 | ||
Preoperative Evaluation | 900 | ||
Techniques | 900 | ||
Graft Configurations | 901 | ||
Results | 901 | ||
Complications | 901 | ||
Postoperative Management | 901 | ||
Conclusions | 903 | ||
Suggested Readings | 903 | ||
The Management of Peripheral Arterial Emboli | 903 | ||
Overview | 903 | ||
Classification, Site, and Source of Embolism | 903 | ||
Pathophysiology | 904 | ||
Clinical Presentation | 904 | ||
Diagnostic Examination | 906 | ||
Management | 907 | ||
Medical Management | 907 | ||
Surgical Management | 907 | ||
Endovascular Approach | 908 | ||
Compartment Syndrome | 908 | ||
Postoperative Management | 908 | ||
Outcomes/Results | 909 | ||
Suggested Readings | 909 | ||
Acute Peripheral Arterial and Bypass Graft Occlusion: | 909 | ||
Overview | 909 | ||
Patient Presentation and Workup | 909 | ||
History and Physical Exam | 909 | ||
Imaging | 910 | ||
Medical Management | 910 | ||
Catheter Directed Thrombolysis | 910 | ||
Results of Thrombolysis | 910 | ||
Techniques of Thrombolysis | 911 | ||
Lytic Agents | 911 | ||
Mechanical Thrombolysis | 912 | ||
Suction Thrombectomy | 912 | ||
Rheolytic Devices | 912 | ||
Rotational/Infusion Devices | 912 | ||
Ultrasonographic | 912 | ||
Conclusion | 914 | ||
Suggested Readings | 914 | ||
Atherosclerotic Renal Artery Disease | 914 | ||
Introduction | 914 | ||
Incidence | 914 | ||
Natural History of Renal Artery Stenosis | 914 | ||
Anatomic Progression | 914 | ||
Functional Progression | 915 | ||
Treatment | 915 | ||
Patient Selection | 915 | ||
Medical Therapy | 915 | ||
Hypertension Control | 915 | ||
Lipid-Lowering Agents | 915 | ||
Antiplatelet Therapy | 915 | ||
Other Risk Modifications | 915 | ||
Surgical Therapy | 916 | ||
Unilateral Renal Artery Stenosis In patients with unilateral RAS, we prefer a retroperitoneal approach to renal revascularization. While direct aortorenal bypass is possible through this exposure, we prefer ileorenal bypass if the common iliac is free of plaque and calcific disease. With the patient in the lateral decubitus position, a curvilinear incision is performed extending from just lateral to the rectus muscle and sheath to the 12th rib (Figure 1). This incision is carried down through the subcutaneous tissue and fascia. The anterior sheath is divided, and the 12th rib is excised. The internal oblique and transversalis muscles are divided, and the retroperitoneum is entered just lateral to the junction of the rectus sheath in the lateral abdominal wall muscles. The peritoneum is then mobilized medially and cephalad. Once the peritoneum is mobilized, the ureter is identified and gently dissected down to the level of the distal common iliac artery inferiorly and superiorly to the level of the renal pelvis. If the dissection is being performed on the left side, it is often necessary to identify and ligate the gonadal vein as well as the inferior lumbar branch of the left renal vein. Once the ureter is mobilized, Gerota’s fascia is entered, and the kidney is circumferentially mobilized. The renal artery is identified and dissected to its junction with the aorta. At this point, the patient is systematically heparinized, the common iliac artery is clamped, and an end-to-side anastomosis is performed to our conduit. We prefer to use saphenous vein, but if deemed unsuitable (<3 mm, sclerotic), PTFE is used. Once the iliac anastomosis is performed, the renal artery is mobilized proximally and doubly ligated with silk suture. Iced slush is applied over the kidney to decrease its temperature, and an end-to-end anastomosis is performed between the conduit and the renal artery in a running or interrupted fashion, depending on the size of the renal artery. Doppler signals confirm flow in the renal artery and the renal parenchyma. In patients with right-sided RAS (Figure 2), it is important to circumferentially mobilize the right renal vein at the lateral border of the inferior vena cava in order to fully dissect the right renal artery. In instances where two small diseased renal arteries are identified (Figure 2, A), it may be necessary to surgically combine the two arteries into one larger orifice to facilitate revascularization (Figure 2,B). | 916 | ||
Bilateral Renal Artery Stenosis | 916 | ||
Other Surgical Options | 916 | ||
Open Surgical Results | 916 | ||
Endovascular Revascularization | 917 | ||
Renal Artery Stenting | 917 | ||
Endovascular Results | 918 | ||
Summary | 918 | ||
Suggested Readings | 918 | ||
Raynaud’s Syndrome | 918 | ||
Overview | 918 | ||
Pathogenesis | 918 | ||
Diagnosis and Presentation | 919 | ||
Treatment | 919 | ||
Conservative Treatment | 919 | ||
Pharmacologic | 920 | ||
Calcium Channel Blockers | 920 | ||
Prostaglandins | 920 | ||
Alpha-2 Adrenoreceptor Blockers | 920 | ||
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers | 921 | ||
Phosphodiesterase Inhibitors | 921 | ||
Endothelin-1 Receptor Antagonist | 921 | ||
Selective Serotonin Reuptake Inhibitors | 922 | ||
Surgical Intervention | 923 | ||
Conclusions | 923 | ||
Suggested Readings | 923 | ||
Thoracic Outlet Syndromes | 924 | ||
Overview | 924 | ||
Anatomy of the Thoracic Outlet | 924 | ||
Arterial Compression | 924 | ||
Venous Compression (Paget-Schroetter Syndrome) | 925 | ||
Nerve Compression | 926 | ||
Transaxillary Approach | 926 | ||
Preparation and Position | 926 | ||
Operative Approach | 926 | ||
Suggested Readings | 927 | ||
The Diabetic Foot | 928 | ||
Introduction | 928 | ||
Pathophysiology | 928 | ||
Presentation | 928 | ||
Treatment | 929 | ||
Conclusion | 930 | ||
Disclaimer | 931 | ||
Suggested Readings | 931 | ||
Gangrene of the Foot | 931 | ||
Overview | 931 | ||
Risk Factors and Epidemiology | 931 | ||
Evaluation | 931 | ||
Clinical Presentation | 931 | ||
Diagnostics | 932 | ||
Ankle-Brachial Index | 932 | ||
Toe-Brachial Index | 932 | ||
Segmental Limb Pressures | 932 | ||
Transcutaneous Oxygen Measurement | 932 | ||
Duplex Ultrasonography | 932 | ||
Multidetector Computed Tomographic Angiography | 933 | ||
Magnetic Resonance Angiography | 933 | ||
Assessment of Metabolic Status | 933 | ||
Management | 933 | ||
Antibiotics and Medical Management | 933 | ||
Débridement | 933 | ||
Revascularization | 933 | ||
Amputations | 933 | ||
Toe Amputation | 934 | ||
Great Toe Amputation | 934 | ||
Lesser Toe Amputations | 934 | ||
Ray Amputation | 934 | ||
Transmetatarsal Amputation | 934 | ||
Syme Amputation | 935 | ||
Transtibial Amputation | 935 | ||
Transfemoral Amputation | 936 | ||
Summary | 936 | ||
Suggested Readings | 936 | ||
Buerger’s Disease (Thromboangiitis Obliterans) | 937 | ||
Introduction | 937 | ||
Clinical Presentation | 937 | ||
Diagnosis | 937 | ||
Treatment | 938 | ||
Prognosis | 939 | ||
Summary | 939 | ||
Suggested Readings | 939 | ||
Acute Mesenteric Ischemia | 939 | ||
Overview | 939 | ||
Anatomy and Collateralization | 939 | ||
Pathophysiology | 940 | ||
Clinical Presentation and Diagnosis | 940 | ||
Treatment | 942 | ||
Initial Management | 942 | ||
Embolism of Mesenteric Artery | 943 | ||
Thrombosis of Mesenteric Artery | 943 | ||
Nonocclusive Mesenteric Ischemia | 944 | ||
Mesenteric Venous Thrombosis | 944 | ||
Endovascular Treatment | 946 | ||
Conclusion | 946 | ||
Suggested Readings | 946 | ||
The Management of Chronic Mesenteric Ischemia | 947 | ||
Arterial Disease | 947 | ||
Reconstruction Options | 947 | ||
Endovascular Techniques | 947 | ||
Endarterectomy | 949 | ||
Bypass | 950 | ||
Antegrade Bypass | 950 | ||
Retrograde Bypass | 951 | ||
Extent of Visceral Artery Reconstruction | 951 | ||
Outcome of Open Revascularization | 952 | ||
Suggested Readings | 952 | ||
Hemodialysis Access Surgery | 953 | ||
Introduction | 953 | ||
Historical Notes | 953 | ||
National Practices and Guidelines | 954 | ||
Preoperative Evaluation | 954 | ||
Operative Techniques | 955 | ||
Autogenous Arm Fistulae | 955 | ||
Radiocephalic Fistula | 955 | ||
Upper-Arm Fistula | 955 | ||
Prosthetic Arteriovenous Grafts | 956 | ||
Special Considerations | 957 | ||
Complications and Management | 957 | ||
Conclusions | 957 | ||
Selected Readings | 957 | ||
Venous Thromboembolism: | 958 | ||
Introduction | 958 | ||
Impact | 958 | ||
Risk Factors | 958 | ||
Prevention and Prophylaxis | 958 | ||
Diagnosis | 959 | ||
Screening of Asymptomatic Patients | 960 | ||
Treatment | 961 | ||
Deep Venous Thrombosis | 961 | ||
Pulmonary Embolism | 961 | ||
Inferior Vena Cava Filters | 962 | ||
Conclusion | 963 | ||
Suggested Readings | 963 | ||
Deep Venous Thrombosis | 963 | ||
Risk Factors | 964 | ||
Diagnosis | 964 | ||
Therapy | 964 | ||
Anticoagulation | 965 | ||
Surgical Thrombectomy | 965 | ||
Thrombolytic Therapy | 965 | ||
Catheter-Directed Thrombolytic Therapy | 965 | ||
Mechanical Thrombectomy | 965 | ||
Permanent Inferior Vena Cava Filters | 966 | ||
Retrievable Inferior Vena Cava Filters | 966 | ||
Special Considerations | 966 | ||
Phlegmasia Alba Dolens and Phlegmasia Cerulea Dolens | 966 | ||
External Compression of Deep Veins | 966 | ||
Internal Jugular Vein/Axillosubclavian Vein Thrombosis | 966 | ||
Superficial Vein Thrombosis | 966 | ||
Suggested Readings | 967 | ||
Vena Cava Filters | 967 | ||
Introduction | 967 | ||
Indications and Contraindications for Inferior Vena Cava Filter Placement and Retrieval | 967 | ||
Filter Selection | 968 | ||
Special Considerations: Suprarenal Inferior Vena Cava Filter | 970 | ||
Special Considerations: Superior Vena Cava Filters | 970 | ||
Contraindications for Placement of Inferior Vena Cava Filter | 970 | ||
Technique | 970 | ||
Filter Retrieval | 971 | ||
Complications | 971 | ||
Discussion | 971 | ||
Suggested Readings | 972 | ||
The Prevention of Venous Thromboembolism | 972 | ||
Epidemiology | 972 | ||
Risk Factors | 972 | ||
Venous Thromboembolism Prophylaxis | 973 | ||
Venous Thromboembolism Diagnosis | 974 | ||
Venous Thromboembolism Treatment | 974 | ||
Inferior Vena Cava Filter | 975 | ||
Catheter-Directed Thrombolytic Therapy | 975 | ||
Systemic Thrombolysis | 975 | ||
Complications | 975 | ||
Summary | 975 | ||
Suggested Readings | 976 | ||
Lymphedema | 976 | ||
Diagnosis | 976 | ||
Treatment | 977 | ||
Nonoperative Management | 977 | ||
Operative Treatment | 978 | ||
Debulking Procedures | 978 | ||
Physiologic Procedures | 979 | ||
Summary | 979 | ||
Suggested Readings | 979 | ||
Trauma and Emergency Care | 981 | ||
Initial Assessment and Resuscitation of the Trauma Patient | 981 | ||
Initial Assessment and Resuscitation of the Trauma Patient | 981 | ||
Stop the Harm and Do No (Further) Harm | 981 | ||
Preparation of the Team and Resuscitation Area | 981 | ||
Primary Survey | 981 | ||
Airway (With Cervical Spine Control) | 981 | ||
Breathing | 982 | ||
Circulation (With Hemorrhage Control) | 982 | ||
Disability (Neurologic Assessment) | 982 | ||
Exposure (With Environmental Control) | 982 | ||
Focused Assessment With Sonography for Trauma | 983 | ||
Resuscitation and Monitoring | 983 | ||
Secondary Survey | 983 | ||
Next Steps | 983 | ||
Suggested Readings | 984 | ||
Airway Management in the Trauma Patient | 984 | ||
Initial Airway Assessment and Therapy | 984 | ||
Rapid Sequence Induction and Intubation | 984 | ||
Endotracheal Intubation | 986 | ||
Supraglottic Airway Devices | 987 | ||
Awake Fiberoptic Intubation | 987 | ||
Airway Management Decision Making | 987 | ||
Surgical Airway | 987 | ||
When and Where to Intubate? Field Versus Emergency Department or Trauma Unit Endotracheal Intubation | 988 | ||
Suggested Readings | 990 | ||
The Surgeon’s Use of Ultrasound in Thoracoabdominal Trauma | 990 | ||
Focused Assessment for the Sonographic Evaluation of the Trauma Patient | 990 | ||
Technique | 990 | ||
Accuracy of the FAST | 991 | ||
Recent Advances and Organ Specificity | 992 | ||
Traumatic Hemothorax | 993 | ||
Technique | 993 | ||
Preoperative and Postoperative Care | 1153 | ||
Fluids and Electrolytes | 1153 | ||
Introduction | 1153 | ||
Fluid Compartments and Osmolality | 1153 | ||
Daily Requirements and Choice of Maintenance Fluids | 1154 | ||
Assessment of Fluid Status and Choice of Replacement Fluids | 1154 | ||
Diagnosis and Treatment of Electrolyte Disorders | 1155 | ||
Sodium | 1155 | ||
Potassium | 1156 | ||
Calcium | 1157 | ||
Magnesium | 1158 | ||
Phosphorus | 1158 | ||
Suggested Readings | 1159 | ||
Preoperative Assessment of the Older Patient: | 1159 | ||
Overview | 1159 | ||
Older Surgical Patients | 1159 | ||
Frailty | 1159 | ||
Frailty, Comorbidity, and Disability | 1160 | ||
Frailty and Surgical Risk Prediction | 1161 | ||
Alternative Measures of Frailty and Surgical Outcomes | 1161 | ||
Sarcopenia and Surgery | 1162 | ||
Logisitics of Preoperative Measurement of Frailty | 1162 | ||
Conclusion | 1162 | ||
Suggested Readings | 1162 | ||
Preoperative Preparation of the Surgical Patient | 1163 | ||
Introduction | 1163 | ||
Oral Intake Guidelines | 1163 | ||
Preoperative Testing | 1163 | ||
Electrocardiograms and Other Cardiac Testing | 1163 | ||
Chest Radiographs | 1163 | ||
Blood Tests | 1164 | ||
Urine Testing | 1165 | ||
Comorbidities | 1165 | ||
Cardiac Disease | 1165 | ||
Ischemia and Stents | 1165 | ||
Pacemakers and Defibrillators | 1166 | ||
Pulmonary Disease | 1166 | ||
Liver Disease | 1166 | ||
Diabetes | 1166 | ||
Renal Disease | 1167 | ||
Obesity | 1167 | ||
Medication Management | 1167 | ||
Angiotensin Converting Enzyme Inhibitors | 1167 | ||
Anticoagulants | 1167 | ||
Beta-Blockers | 1168 | ||
Herbal Medications | 1168 | ||
Opiates | 1168 | ||
Proton Pump Inhibitors and Histamine-2 Blockers | 1168 | ||
Summary | 1168 | ||
Suggested Readings | 1169 | ||
Is a Nasogastric Tube Necessary After Alimentary Tract Surgery? | 1169 | ||
Suggested Readings | 1171 | ||
Surgical Site Infections | 1172 | ||
Overview | 1172 | ||
Definition | 1172 | ||
Risk Factors | 1172 | ||
Prevention | 1172 | ||
Patient Preparation | 1172 | ||
Immediate Preoperative Prevention | 1172 | ||
Prophylactic Antibiotics (SCIP INF 1 to 3) | 1172 | ||
Appropriate Hair Removal (SCIP INF 6) | 1173 | ||
Postoperative Normoglycemia (SCIP INF 4) | 1173 | ||
Postoperative Normothermia (SCIP INF 10) | 1174 | ||
Performance Measures | 1175 | ||
Intraoperative and Postoperative Incision Management | 1176 | ||
Special Considerations | 1176 | ||
Treatment | 1176 | ||
Summary | 1177 | ||
Suggested Readings | 1177 | ||
The Management of Intra-abdominal Infections | 1177 | ||
Introduction | 1177 | ||
Definitions | 1177 | ||
Diagnostics | 1178 | ||
Intra-abdominal Infections Following Abdominal Trauma or Surgery | 1178 | ||
Management of Intra-abdominal Infections | 1179 | ||
Source Control: Operation Versus Percutaneous Drainage Alone | 1179 | ||
Suggested Readings | 1181 | ||
Occupational Exposure to Human Immunodeficiency Virus and Other Bloodborne Pathogens | 1181 | ||
Progress in the Field | 1181 | ||
Occupational Exposure to Bloodborne Pathogens | 1182 | ||
Occupational Exposure to Human Immunodeficiency Virus | 1182 | ||
Risk | 1182 | ||
Efficacy of Zidovudine | 1183 | ||
Management of an Exposure | 1183 | ||
Testing the Source | 1183 | ||
Counseling | 1183 | ||
Timing of Initiation of Antiretroviral Drugs | 1183 | ||
Healthcare Worker Counseling | 1183 | ||
Antiretroviral Regimens | 1184 | ||
Management of the Injury Site | 1184 | ||
Source Testing | 1184 | ||
Monitoring the Exposed Healthcare Worker | 1184 | ||
Expert Opinion | 1184 | ||
Occupational Exposure to Hepatitis B | 1184 | ||
Occupational Exposure to Hepatitis C | 1185 | ||
Healthcare Worker with Hepatitis C Virus RNA | 1185 | ||
Suggested Readings | 1185 | ||
Antifungal Therapy in the Surgical Patient | 1186 | ||
Introduction | 1186 | ||
Antifungal Agents | 1186 | ||
Polyenes | 1186 | ||
Amphotericin B | 1186 | ||
Azoles | 1188 | ||
Fluconazole | 1188 | ||
Voriconazole | 1188 | ||
Posaconazole | 1188 | ||
Itraconazole | 1188 | ||
Echinocandins | 1189 | ||
Specific Infections | 1189 | ||
Candidiasis | 1189 | ||
Mucocutaneous Disease | 1190 | ||
Cutaneous Candidiasis | 1190 | ||
Vulvovaginal Candidiasis | 1190 | ||
Oropharyngeal and Esophageal Candidiasis | 1190 | ||
Invasive Candidiasis | 1190 | ||
Filamentous Fungi | 1191 | ||
Aspergillosis | 1191 | ||
Zygomycetes | 1191 | ||
Conclusions | 1192 | ||
Suggested Readings | 1192 | ||
Measuring Outcomes in Surgery | 1192 | ||
Introduction | 1192 | ||
Donabedian Model of Quality | 1192 | ||
Variation in Outcomes | 1193 | ||
Current Measures of Outcomes | 1193 | ||
Mortality | 1193 | ||
Morbidity | 1194 | ||
Composite Measures | 1194 | ||
Patient-Centered Outcomes | 1194 | ||
Integrating Outcome Measurement Into the Current Practice of Surgery | 1195 | ||
Benchmarking and Performance Feedback | 1195 | ||
Quality Collaboratives | 1196 | ||
Maintenance of Certification | 1196 | ||
The Importance of Outcome Measurement in Research | 1197 | ||
Comparative Effectiveness Research | 1197 | ||
Patient-Centered Outcomes Research | 1197 | ||
Conclusion | 1197 | ||
Suggested Readings | 1197 | ||
Comparative Effectiveness Research in Surgery | 1198 | ||
Introduction | 1198 | ||
What is Comparative Effectiveness Research? | 1198 | ||
Effectiveness Versus Efficacy | 1198 | ||
Which Treatment? | 1198 | ||
Which Patients? | 1199 | ||
Which Outcome? | 1199 | ||
How is Comparative Effectiveness Research Done? | 1200 | ||
Comparative Effectiveness Research in the National and International Spotlight | 1201 | ||
Controversy | 1201 | ||
Future Directions | 1202 | ||
Suggested Readings | 1202 | ||
Surgical Critical Care | 1203 | ||
Surgical Palliative Care | 1203 | ||
Suggested Readings | 1211 | ||
Cardiovascular Pharmacology | 1211 | ||
Overview | 1211 | ||
Tachyarrhythmias | 1211 | ||
Narrow QRS Dysrhythmias | 1211 | ||
Wide QRS Dysrhythmias | 1212 | ||
Bradydysrhythmias | 1212 | ||
Control of Cardiac and Systemic Vascular Performance | 1212 | ||
Control of Preload | 1212 | ||
Control of Myocardial Contractility | 1212 | ||
Left Ventricular Failure | 1212 | ||
Chronic Systolic Heart Failure | 1213 | ||
Acute Systolic Heart Failure | 1213 | ||
Acute Myocardial Ischemia | 1214 | ||
Right Ventricular Failure | 1214 | ||
Left Ventricular Diastolic Dysfunction | 1215 | ||
Control of Afterload | 1215 | ||
Treatment of Systemic Hypertension | 1215 | ||
Pharmacologic Reduction of Perioperative Cardiac Risk | 1216 | ||
Suggested Readings | 1217 | ||
Glucose Control in the Postoperative Period | 1217 | ||
Introduction | 1217 | ||
Indications | 1217 | ||
Techniques | 1218 | ||
Results | 1218 | ||
Summary | 1218 | ||
Suggested Readings | 1218 | ||
Postoperative Respiratory Failure | 1219 | ||
Introduction | 1219 | ||
Acute Respiratory Failure | 1219 | ||
Classification and Epidemiology | 1219 | ||
ARF Treatment: Noninvasive Ventilation | 1219 | ||
ARF Treatment: Intubation | 1219 | ||
Treatment: VAP Prevention | 1220 | ||
Treatment: Mechanical Ventilation | 1221 | ||
Modes of Mechanical Ventilation | 1224 | ||
Volume Modes | 1224 | ||
Pressure Modes | 1224 | ||
Advanced Modes of Mechanical Ventilation in the ICU | 1225 | ||
Mechanical Ventilation Strategies for ALI and ARDS | 1225 | ||
Adjuncts to Mechanical Ventilation in Patients with ARDS and Severe Hypoxemia | 1227 | ||
Incremental Approach to the Management of Severe ARDS | 1227 | ||
Weaning and Liberation From Mechanical Ventilation | 1229 | ||
Tracheostomy | 1230 | ||
Suggested Readings | 1230 | ||
Ventilator-Associated Pneumonia | 1230 | ||
Introduction | 1230 | ||
Diagnosis | 1230 | ||
Treatment | 1231 | ||
Summary | 1232 | ||
Suggested Readings | 1232 | ||
Extracorporeal Membrane Oxygenation for Respiratory Failure in Adults | 1233 | ||
Introduction | 1233 | ||
The Extracorporeal Membrane Oxygenation System | 1233 | ||
Indications | 1233 | ||
Contraindications | 1233 | ||
Technique | 1233 | ||
Management | 1235 | ||
Ventilator Management | 1235 | ||
Systemic Anticoagulation | 1235 | ||
Sedatives and Analgesia | 1235 | ||
Renal | 1235 | ||
Infection | 1236 | ||
Troubleshooting the ECMO | 1236 | ||
Recirculation | 1236 | ||
Superior Vena Cava Syndrome | 1236 | ||
Persistent Hypoxia | 1236 | ||
Hemolysis | 1236 | ||
Thrombocytopenia | 1236 | ||
Weaning and Lung Recovery | 1237 | ||
Discussion | 1237 | ||
Suggested Readings | 1238 | ||
Tracheostomy | 1238 | ||
Introduction | 1238 | ||
Indications and Contraindications | 1238 | ||
Timing | 1238 | ||
Open Tracheostomy | 1239 | ||
Percutaneous Dilatational Tracheostomy | 1239 | ||
Emergent Cricothyroidotomy | 1240 | ||
Complications | 1240 | ||
Early Complications | 1240 | ||
Late Complications | 1241 | ||
Tracheostomy Types, Postoperative Care, and Decannulation | 1241 | ||
Summary | 1241 | ||
Suggested Readings | 1241 | ||
Acute Kidney Failure | 1242 | ||
Overview | 1242 | ||
Definitions | 1242 | ||
Diagnosis of Acute Kidney Injury | 1242 | ||
Radiologic Imaging | 1243 | ||
Medication Review | 1244 | ||
Differential Diagnosis | 1244 | ||
Prerenal Azotemia | 1244 | ||
Postrenal Azotemia | 1245 | ||
Intrinsic Renal Disease | 1245 | ||
Glomerular Disease | 1245 | ||
Interstitial Disease | 1245 | ||
Tubular Disease | 1245 | ||
Renal Protective Strategies | 1245 | ||
Prevention of Contrast-Induced Nephropathy | 1245 | ||
Other Preventive Strategies | 1246 | ||
Treatment | 1246 | ||
Renal Replacement Therapy | 1246 | ||
Timing of Initiation of Renal Replacement Therapy | 1246 | ||
Frequency and Rate of Renal Replacement Therapy | 1246 | ||
Modalities for Renal Replacement Therapy | 1247 | ||
Prognosis | 1247 | ||
Suggested Readings | 1247 | ||
Electrolyte Disorders | 1247 | ||
Overview | 1247 | ||
Sodium | 1248 | ||
Homeostasis | 1248 | ||
Hyponatremia | 1248 | ||
Hypernatremia | 1250 | ||
Potassium | 1251 | ||
Homeostasis | 1251 | ||
Hypokalemia | 1251 | ||
Hyperkalemia | 1251 | ||
Magnesium | 1252 | ||
Minimally Invasive Surgery | 1305 | ||
Laparoscopic Cholecystectomy | 1305 | ||
Introduction | 1305 | ||
Indications for Cholecystectomy | 1305 | ||
Imaging Diagnosis | 1305 | ||
Complicated Gallstone Disease | 1305 | ||
Biliary Dyskinesia/Chronic Acalculous Cholecystitis | 1306 | ||
Gallbladder Polyps | 1306 | ||
Laparoscopic Cholecystectomy Technique | 1307 | ||
Initial Access | 1307 | ||
Basic Technique | 1307 | ||
Critical View of Safety Method of Ductal Identification | 1307 | ||
Intraoperative Cholangiography | 1308 | ||
The Difficult Cholecystectomy | 1309 | ||
Multiple Prior Abdominal Operations | 1309 | ||
Acute Cholecystitis | 1309 | ||
Percutaneous Cholecystostomy | 1309 | ||
Portal Hypertension and Cirrhosis | 1310 | ||
Alternative Approaches: Single-Incision Laparoscopic and Notes Cholecystectomy | 1310 | ||
Complications | 1310 | ||
Summary | 1310 | ||
Suggested Readings | 1310 | ||
Laparoscopic Common Bile Duct Exploration | 1311 | ||
Introduction | 1311 | ||
Intraoperative Evaluation of Common Bile Duct Stones | 1311 | ||
Techniques | 1312 | ||
After Cholecystectomy | 1315 | ||
Efficacy of Laparoscopic Common Bile Duct Exploration | 1315 | ||
Alternative Management | 1315 | ||
Summary | 1316 | ||
Suggested Readings | 1316 | ||
Laparoscopic 360-Degree Fundoplication | 1317 | ||
Background | 1317 | ||
Symptoms and Complications | 1317 | ||
Medical Therapy | 1317 | ||
Diagnostic Workup | 1317 | ||
Endoscopy | 1317 | ||
Barium Swallow | 1317 | ||
pH Testing | 1317 | ||
Impedance Testing | 1317 | ||
Surgical Therapy | 1317 | ||
Reasons for Surgery | 1317 | ||
Patient Selection and Predictors of Success | 1318 | ||
Technique | 1318 | ||
Positioning | 1318 | ||
Port Placement | 1318 | ||
Early Gastric Mobilization | 1319 | ||
Left to Right Crural Dissection and Esophageal Mobilization | 1319 | ||
Crural Closure | 1319 | ||
Creation of Tension-free Fundoplication | 1320 | ||
Additional Maneuvers and Controversy | 1321 | ||
Postoperative Care | 1321 | ||
Complications | 1321 | ||
Outcomes | 1321 | ||
Conclusion | 1321 | ||
Suggested Readings | 1322 | ||
Laparoscopic Appendectomy | 1322 | ||
Introduction | 1322 | ||
Pathophysiology | 1322 | ||
Diagnosis | 1322 | ||
Indications | 1323 | ||
Techniques | 1323 | ||
Results | 1324 | ||
Special Considerations | 1324 | ||
Pregnancy | 1324 | ||
Incorrect Diagnosis | 1325 | ||
Complicated Appendicitis | 1325 | ||
Interval Appendectomy After Nonoperative Management | 1325 | ||
Summary | 1325 | ||
Suggested Readings | 1325 | ||
Laparoscopic Inguinal Herniorrhaphy | 1325 | ||
Overview | 1325 | ||
Evaluating the Patient | 1326 | ||
Relevant Anatomy | 1326 | ||
Indications and Contraindications | 1326 | ||
Preparing the Patient | 1327 | ||
Totally Extraperitoneal | 1328 | ||
Transabdominal Preperitoneal | 1331 | ||
Management of Complicated Hernia | 1332 | ||
After Surgery | 1332 | ||
Complications | 1332 | ||
Summary | 1333 | ||
Acknowledgment | 1333 | ||
Suggested Readings | 1334 | ||
Laparoscopic Repair of Recurrent Inguinal Hernias | 1334 | ||
Overview | 1334 | ||
Indications and Choice of the Repair | 1334 | ||
Laparoscopic Repair of Recurrent Inguinal Hernias | 1335 | ||
TEP Versus TAPP | 1335 | ||
Operative Considerations | 1335 | ||
Outcomes | 1336 | ||
Suggested Readings | 1337 | ||
Laparoscopic Ventral Hernia Repair | 1337 | ||
Introduction | 1337 | ||
Indications | 1337 | ||
Preoperative Workup | 1338 | ||
Operative Technique | 1338 | ||
Patient Positioning | 1338 | ||
Access of the Reoperative Abdomen and Trocar Positioning | 1338 | ||
Adhesiolysis | 1339 | ||
Sizing the Hernia Defect | 1339 | ||
Mesh Positioning | 1340 | ||
Postoperative Care | 1341 | ||
Special Circumstances | 1341 | ||
Subxiphoid Hernia | 1341 | ||
Suprapubic Hernia | 1341 | ||
Defect Closure | 1341 | ||
Complications | 1341 | ||
Outcomes | 1342 | ||
Suggested Readings | 1342 | ||
Laparoscopic Repair of Peristomal Hernias | 1342 | ||
Background | 1342 | ||
Indications and Contraindications | 1342 | ||
Preoperative Planning | 1343 | ||
Preoperative Preparation | 1343 | ||
Surgery | 1343 | ||
Patient Positioning and Preparation | 1343 | ||
Instrument/Monitor Positioning | 1343 | ||
Port Selection and Placement | 1343 | ||
Operative Technique | 1343 | ||
Division of Adhesions and Reduction of Hernia | 1343 | ||
Postoperative Management | 1344 | ||
Complications | 1344 | ||
Results | 1344 | ||
Conclusions | 1345 | ||
Suggested Readings | 1345 | ||
Laparoscopic Splenectomy | 1345 | ||
Overview | 1345 | ||
Indications and Contraindications | 1345 | ||
Preoperative Preparation | 1345 | ||
Techniques | 1345 | ||
Right Lateral Approach | 1346 | ||
Anterior Approach | 1348 | ||
Laparoscopic Hand-Assisted | 1348 | ||
Postoperative Care | 1348 | ||
Complications | 1348 | ||
Results | 1349 | ||
Summary | 1349 | ||
Suggested Readings | 1349 | ||
Laparoscopic Gastric Surgery | 1349 | ||
Overview | 1349 | ||
Indications and Rationale for Laparoscopic Gastrectomy | 1349 | ||
Contraindications | 1350 | ||
Preoperative Workup and Preparation | 1350 | ||
Surgical Principles for Laparoscopic Gastrectomy | 1350 | ||
Pitfalls during a Laparoscopic Gastrectomy | 1350 | ||
Extent of Lymphadenectomy | 1350 | ||
Omentectomy and Bursectomy | 1350 | ||
Technique of Laparoscopic Gastrectomy | 1350 | ||
Room Setup and Patient Position | 1351 | ||
Placement of Ports | 1351 | ||
Dissection of Greater Omentum and Left Gastroepiploic Vessels (Nos. 4d and 4sb Lymph Nodes) | 1351 | ||
Dissection of Greater Omentum and Right Gastroepiploic Arcade (No. 4d Lymph Nodes) | 1351 | ||
Infrapyloric Dissection (No. 6 Lymph Nodes) | 1353 | ||
Suprapyloric Dissection of Right Gastric Artery and Proper Hepatic Artery (Nos. 5 and 12a Lymph Nodes) | 1353 | ||
Suprapancreatic Dissection of Left Gastric, Common Hepatic, Celiac Trunk, and Proximal Splenic Artery Lymph Nodes (Nos. 7, 8a, 9, and 11p Lymph Nodes) | 1356 | ||
Dissection Along Lesser Curvature of Stomach (Nos. 1 and 3 Lymph Nodes) | 1356 | ||
Techniques of Reconstruction | 1356 | ||
Techniques of Billroth I Anastomosis | 1358 | ||
Extracorporeal Modified Double-Stapled Circular End-to-End Gastroduodenostomy | 1358 | ||
Extracorporeal Side-to-End Circular Gastroduodenostomy | 1359 | ||
Intracorporeal Delta-Shaped Gastroduodenostomy | 1359 | ||
Billroth II Reconstruction | 1359 | ||
Roux-en-Y Reconstruction | 1361 | ||
Special Considerations | 1362 | ||
Laparoscopic Total Gastrectomy | 1362 | ||
Total Omentectomy | 1362 | ||
Robot-Assisted Gastrectomy | 1362 | ||
Suggested Readings | 1363 | ||
Laparoscopic Management of Crohn’s Disease | 1363 | ||
Overview | 1363 | ||
Stomach and Duodenum | 1364 | ||
Operative Technique: Laparoscopic Gastrojejunostomy | 1364 | ||
Outcomes | 1364 | ||
Small Bowel | 1364 | ||
Operative Technique: Laparoscopy-Assisted Small Bowel Resection | 1364 | ||
Operative Technique: Laparoscopy-Assisted Ileocolic Resection | 1365 | ||
Outcomes | 1365 | ||
Colon and Rectum | 1365 | ||
Operative Technique: Laparoscopy-Assisted Total Abdominal Colectomy | 1365 | ||
Operative Technique: Totally Laparoscopic Total Proctocolectomy | 1367 | ||
Outcomes | 1368 | ||
Perineum | 1368 | ||
Operative Technique: Laparoscopic Fecal Diversion | 1368 | ||
Outcomes | 1369 | ||
Summary | 1369 | ||
Suggested Readings | 1369 | ||
Laparoscopic Colon and Rectal Surgery | 1369 | ||
Background | 1369 | ||
Operative Principles and Technical Pearls | 1370 | ||
Crohn’s Disease | 1375 | ||
Ulcerative Colitis | 1375 | ||
Diverticulitis | 1376 | ||
Colon Cancer | 1376 | ||
Rectal Cancer | 1376 | ||
Complications and Learning Curve of Laparoscopic Colectomy | 1377 | ||
Suggested Readings | 1377 | ||
Minimally Invasive Esophagectomy | 1378 | ||
Overview | 1378 | ||
Indications | 1378 | ||
Preoperative Preparation | 1378 | ||
Minimally Invasive Ivor Lewis Esophagectomy | 1378 | ||
Surgical Technique | 1378 | ||
Laparoscopic Transhiatal Esophagectomy | 1380 | ||
Thoracoscopic and Laparoscopic Esophagectomy with Cervical Anastomosis | 1381 | ||
Postoperative Care | 1384 | ||
Results | 1384 | ||
Summary | 1384 | ||
Suggested Readings | 1384 | ||
Laparoscopic Treatment of Esophageal Motility Disorders | 1384 | ||
Introduction | 1384 | ||
Laparoscopic Heller Myotomy and Partial Fundoplication for Achalasia | 1385 | ||
Revisional Surgery after Heller Myotomy | 1387 | ||
Laparoscopic Treatment of End-Stage Achalasia | 1387 | ||
Laparoscopic Treatment of Epiphrenic Diverticula | 1387 | ||
Summary | 1388 | ||
Suggested Readings | 1388 | ||
Laparoscopic Adrenalectomy | 1389 | ||
Introduction | 1389 | ||
Indications | 1389 | ||
Techniques | 1389 | ||
Patient Position | 1389 | ||
Lateral Approach | 1389 | ||
Posterior Approach | 1390 | ||
Complications | 1390 | ||
Postoperative Care | 1391 | ||
Outcomes | 1391 | ||
The Future: Even LESS Invasive Surgery | 1391 | ||
Single-incision Laparoscopic Surgery Approach | 1392 | ||
Mini-Laparoscopy | 1393 | ||
Robot-Assisted Laparoscopic Adrenalectomy | 1393 | ||
NOTES Adrenalectomy | 1393 | ||
Selected Readings | 1393 | ||
Minimally Invasive Parathyroidectomy | 1393 | ||
Preoperative Parathyroid Localization | 1394 | ||
Intraoperative Adjuncts | 1395 | ||
Surgical Approach | 1396 | ||
Postoperative Management | 1398 | ||
Suggested Readings | 1398 | ||
Laparoscopic Liver Resection | 1398 | ||
Overview | 1398 | ||
Preoperative Evaluation | 1399 | ||
Systems-Based Clinical Evaluation | 1399 | ||
Axial Imaging Preoperative Planning | 1399 | ||
Relative Contraindications to Laparoscopy | 1399 | ||
Anesthesia and Intraoperative Monitoring | 1400 | ||
Operative Techniques | 1400 | ||
Pure Laparoscopy | 1400 | ||
Hand-Assisted Technique and the Hybrid Technique | 1400 | ||
Right Hepatectomy Using the Hybrid Technique | 1401 | ||
Left Hepatectomy Using the Hybrid Technique | 1402 | ||
Operative Metrics | 1402 | ||
Conclusion | 1402 | ||
Suggested Readings | 1402 | ||
Staging Laparoscopy for Gastrointestinal Cancer | 1403 | ||
Overview | 1403 | ||
General Technique | 1403 | ||
Esophageal Cancer | 1403 | ||
Gastric Adenocarcinoma | 1403 | ||
Colorectal Liver Metastasis and Hepatobiliary Primary Tumors | 1404 | ||
Pancreatic and Periampullary Adenocarcinomas | 1404 | ||
Lymphoproliferative Diseases | 1405 | ||
Natural Orifice Transluminal Endoscopic Surgery | 1405 | ||
Summary | 1405 | ||
Suggested Readings | 1405 | ||
Laparoscopic Pancreas Surgery | 1405 | ||
Laparoscopic Whipple | 1406 | ||
Technique | 1406 | ||
Laparoscopic Distal Pancreatectomy | 1407 | ||
Preoperative Tattooing | 1408 | ||
Technique | 1408 | ||
Laparoscopic Distal Pancreatectomy With Splenectomy | 1409 | ||
Patient Outcomes | 1409 | ||
Laparoscopic Central Pancreatectomy | 1409 | ||
Laparoscopic Total Pancreatectomy with Islet Autotransplantation | 1409 | ||
Older and High-Risk Patients | 1409 | ||
Conclusion | 1409 | ||
Acknowledgments | 1410 | ||
Suggested Readings | 1410 | ||
Laparoscopic Bypass for Pancreatic Cancer | 1410 | ||
Background | 1410 | ||
Gastric Outlet Obstruction | 1410 | ||
Laparoscopic Gastrojejunostomy | 1410 | ||
Laparoscopic Biliary Bypass Procedures | 1411 | ||
Laparoscopic Cholecystojejunostomy | 1412 | ||
Laparoscopic Choledochoduodenostomy | 1412 | ||
Laparoscopic Choledochojejunostomy | 1412 | ||
Conclusions | 1413 | ||
Suggested Readings | 1413 | ||
Laparoscopic Management of Pancreatic Pseudocyst | 1414 | ||
Overview | 1414 | ||
Clinical Features | 1414 | ||
Preoperative Workup | 1414 | ||
Operative Indications | 1414 | ||
Procedure Selection | 1414 | ||
Preoperative Planning | 1415 | ||
Laparoscopic Cystgastrostomy | 1415 | ||
Anterior Approach | 1415 | ||
Posterior Approach | 1417 | ||
Laparoscopic Cystjejunostomy | 1417 | ||
Postoperative Care | 1418 | ||
Outcomes and Complications | 1418 | ||
Brief Comment on Walled-Off Necrosis | 1418 | ||
Suggested Readings | 1418 | ||
Video-Assisted Thoracic Surgery | 1418 | ||
Introduction | 1418 | ||
Indications for Video-Assisted Thoracic Surgery and Patient Selection | 1418 | ||
Surgical Setup and Equipment | 1419 | ||
Anesthesia | 1419 | ||
Patient Positioning | 1419 | ||
Equipment | 1419 | ||
Port Site Placement | 1421 | ||
Basic Technique and Emergency Conversion to Thoracotomy | 1422 | ||
Basic Technique of Video-Assisted Thoracic Surgery | 1422 | ||
Conversion to Thoracotomy | 1422 | ||
Summary | 1422 | ||
Suggested Readings | 1422 | ||
Laparoscopic Surgery for Morbid Obesity | 1422 | ||
Preoperative Evaluation | 1423 | ||
Preparing the Patient in the Operating Room | 1424 | ||
Techniques | 1424 | ||
Laparoscopic Antecolic Antegastric Roux-en-Y Gastric Bypass Operative Technique | 1424 | ||
Laparoscopic Adjustable Gastric Band | 1426 | ||
Laparoscopic Vertical Sleeve Gastrectomy | 1427 | ||
Laparoscopic Biliopancreatic Diversion With Duodenal Switch | 1429 | ||
Laparoscopic Gastric Plication | 1430 | ||
Postoperative Management | 1430 | ||
Outcomes and Complications | 1432 | ||
Endoscopic Approaches to the Management of Obesity | 1433 | ||
Comments | 1433 | ||
Suggested Readings | 1433 | ||
Laparoscopic Donor Nephrectomy | 1434 | ||
Overview | 1434 | ||
Evaluation of the Live Kidney Donor | 1434 | ||
Contraindications | 1434 | ||
Operative Approach | 1434 | ||
Postoperative Management | 1435 | ||
Risks | 1436 | ||
Conclusion | 1436 | ||
Selected Readings | 1436 | ||
Laparoendoscopic Single-Site Surgery as an Evolving Surgical Approach | 1436 | ||
Training and Learning Curve | 1436 | ||
Devices and Instruments | 1437 | ||
Transumbilical Approach | 1438 | ||
Nephrectomy | 1438 | ||
Cholecystectomy | 1438 | ||
Bariatric Surgery | 1440 | ||
Colectomy | 1440 | ||
Urgent Indications | 1440 | ||
Urologic Surgery | 1440 | ||
Gynecologic Surgery | 1440 | ||
Robotic Single-Port Approach | 1440 | ||
Cost Considerations | 1441 | ||
Consent Issues | 1441 | ||
Strategies for Successful Incorporation of the Single-Port Technique | 1442 | ||
Conclusions | 1443 | ||
Suggested Readings | 1443 | ||
NOTES: | 1443 | ||
Overview | 1443 | ||
Treatment and Methods | 1443 | ||
NOTES: What Will be Possible in the Near Future? | 1445 | ||
Suggested Readings | 1446 | ||
index | 1447 | ||
A | 1447 | ||
B | 1451 | ||
C | 1453 | ||
D | 1458 | ||
E | 1460 | ||
F | 1462 | ||
G | 1464 | ||
H | 1466 | ||
I | 1468 | ||
J | 1471 | ||
K | 1471 | ||
L | 1471 | ||
M | 1473 | ||
N | 1475 | ||
O | 1476 | ||
P | 1476 | ||
Q | 1482 | ||
R | 1482 | ||
S | 1484 | ||
T | 1489 | ||
U | 1492 | ||
V | 1492 | ||
W | 1493 | ||
Z | 1493 |